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ABSTRACT
PRESENCE OF PSYCHOSOCIAL SYMPTOMS IN YOUNG ADULT STROKE
SURVIVORS POST-ACUTE THROMBECTOMY FOR ISCHEMIC STROKE
by
KAREN B. SEAGRAVES
Young adults are the fastest growing population of stroke patients. Current
treatments enable physicians to reverse hyper-acute large vessel ischemic stroke, and
young adult stroke survivors (YASS) are increasingly discharged directly home with few
to no apparent neurological deficits. No studies have examined the psychosocial
experiences these YASS have once they are home and whether these experiences are
associated with stroke-specific quality of life (SSQOL). The purpose of this study was to
describe YASS post-stroke symptoms, their understanding and perception of those
symptoms, and to examine relationships among psychosocial variables: anxiety,
depression, fatigue, illness threat perceptions and SSQOL.
A cross-sectional, exploratory design was used. YASS 18-55 years of age and 118 months post-stroke who received a thrombectomy at a metropolitan, comprehensive
stroke center and discharged directly home were recruited. Demographic and clinical data
(e.g. NIHSS, mRS scores) were collected from the hospital’s electronic medical record.
Participants completed questionnaires to assess psychosocial variables using an online or
paper survey. Data were analyzed using SPSS version 25. Descriptive statistics and
Spearman rho correlations were performed.
Participants (N = 14) had a mean age 45 years (SD = 6.2), were 4-18 months poststroke, 71% female, 57% Black, and had discharge NIHSS scores indicating minimal
vi

neurological deficits (M = 2, SD = 2.6). Five participants were identified as having
clinically severe fatigue; three had borderline cases. There was one case of clinically
significant anxiety with one borderline case, and one case of clinically significant
depression with three borderline cases. All participants perceived some level of threat of
the symptoms they were experiencing, and overall SSQOL was decreased. Higher levels
of fatigue, anxiety, depression and illness perception threat were significantly related to
lower SSQOL.
In spite of being discharged home with minimal to no physical deficits, this
sample of YASS described psychosocial symptoms, notably fatigue, that may impact
recovery and transition back to the community. Further research is needed with a larger
sample of these YASS to evaluate their psychosocial needs. Symptom assessments,
provision of education, resources and ongoing support before and after discharge home
may be beneficial.
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CHAPTER I
INTRODUCTION
Young adults are the fastest growing population of stroke patients. From 20002010, 10% of strokes in the United States occurred in adults between the ages of 18-50
years (Mozaffarian et al., 2015). This age range is comprised of adults who are in their
productive work years, often raising children and caring for elderly parents. Between
1990-2015, of all neurological disorders, stroke accounted for the highest percentage of
disability-adjusted life years worldwide (Global Burden of Disease, 2017). The potential
for prolonged recovery time, decades of living with disability, the higher economic cost
of stroke care, and the looming prospect of future stroke can all be devastating sequelae
of stroke in the young adult. Although stroke mortality has declined from the 3rd to the 5th
leading cause of death in the United States because of technological advances, stroke
remains the leading cause of adult disability (Mozaffarian, 2015). However, new
technologies may further help in preventing or minimizing disability (Powers et al.,
2018).
New technological advances now enable physicians to halt an acute stroke, restore
blood flow, and prevent or minimize permanent damage to the brain. In 2015, at the
American Heart Association/ American Stroke Association (AHA/ASA) International
Stroke Conference, the world’s leading authorities on stroke announced that endovascular
thrombectomy for large vessel acute ischemic stroke is supported by level 1A evidence
and is the new standard of care for patients within 6 hours of stroke onset (Saver et al.,
1
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2015). In March, 2017, the DAWN trial, which investigated thrombectomy for large
vessel occlusion in the 6 to 24-hour window from stroke ictus, was stopped early for
efficacy after interim review (Nogueira et al., 2017). The DAWN trial demonstrated that
with the appropriate clinical exam, imaging, and device utilization, that wake-up or latediscovery stroke patients (6 to 24 hours from onset) undergoing thrombectomy, had up to
73% better outcomes than those not treated (Nogueira et al., 2017). Results from the
National Institutes of Health funded DEFUSE3 trial were announced at the 2018
AHA/ASA International Stroke Conference, providing additional evidence that late
treatment with thrombectomy, up to 16 hours post-onset, reduces death and disability
(Albers et al., 2018). As a result of the above trials, there is increasing evidence of better
outcomes (reduced mortality, less physical disability, increase in functional
independence), wider availability of the endovascular procedures for stroke, and clinical
acceptance of these treatments. Compared to older adults, young adults may benefit more
from these new technologies and expanded time window, because young adults are less
likely to be excluded from treatment for pre-existing disability or dementia, based on the
current trials’ inclusion and exclusion criteria. Therefore, more young adults experiencing
large vessel stroke are receiving treatment, and rapidly recovering from severe
neurological symptoms. As a result, many of these young adult stroke survivors (YASS)
are discharged directly from the hospital to home because they have few to no apparent
neurological deficits.
Problem
YASS who escape visible neurological injury, as measured by the National
Institutes of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) scores may
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be discharged to home from the acute hospital setting, and often do not require
rehabilitation for physical disabilities and follow up (Goyal et al., 2016; Plath et al.,
2016). As a result, there is little opportunity to screen these YASS for post-stroke
problems. Therefore, little is known about their understanding and perceptions of
symptoms after experiencing this potentially life-threatening event. Research has
indicated that despite the absence of neurological deficits at discharge, this population
describes experiencing unexpected and invisible symptoms that can be categorized as
depressive symptoms and cognitive deficits including executive dysfunction (Sobreiro et
al., 2014). In general, depressive symptoms are common post stroke; one-third of stroke
patients develop depression (Hackett & Pickles, 2014).
Prior to hospital discharge following stroke, there are requirements for patients to
receive stroke education. However, the required stroke education elements based upon
the standards for the four levels of Joint Commission Stroke Center certification do not
include information about ongoing effects of stroke, but rather focus on risk factors,
when to call 911 and the signs and symptoms of acute stroke (Specifications Manual,
2018). Only hospitals that are certified as comprehensive stroke centers are directed to
address cognitive deficits or depressive symptoms, and as of 2012 it became a
requirement for comprehensive stroke centers to screen for depression in stroke patients
(Facts about Comprehensive Stroke Center Certification, 2015). Education for this
emerging population of YASS may be inadequate to address their unique needs,
including potential symptoms post-stroke.
In general, the best way to screen for depression and cognitive changes, and the
optimal time when these screenings should occur in stroke survivors is unclear to
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clinicians. Stroke survivors with physical and mental disabilities require rehabilitation,
and transition to acute inpatient rehabilitation units or centers. Most rehabilitation centers
have robust opportunities for emotional and social support, and treatment for depression,
fatigue and anxiety. YASS who discharge directly home are without those opportunities
(Sadler et al., 2014). Symptoms that may include depression, cognitive changes, fatigue,
and anxiety can affect the quality of life, productivity, and ultimately a successful
transition back into the community for this population of YASS.
Significance and Purpose
There is a growing population of young adults having strokes, a wider acceptance
and availability of technological advances and an expanding time window in
interventional treatment for acute stroke, which will lead to more YASS who discharge
directly home because of minimal to no neurological deficits. However, no studies have
examined the psychosocial experiences these YASS have once they discharge home and
whether these experiences are associated with quality of life.
In preparation for home-going, nurses in the acute setting hold the primary
responsibility of providing initial, ongoing and discharge education and require
information and guidance for this teaching. Several meta-analyses have been published
that address the 90 day to two year post-acute intervention periods in patients of all ages
treated for large vessel ischemic stroke, but the primary focus of these meta-analyses
have been functional outcomes and mortality (Mistry et al., 2017; Vidale & Agostoni,
2017; van den Berg et al., 2017). Quality of life and the presence of fatigue, anxiety and
depressive symptoms have not been independently investigated in patients treated with
thrombectomy for large vessel ischemic stroke. Unmet psychosocial and cognitive needs
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may impede reentry into the workforce, parenting, caring for aging parents and
relationships with partners. While other YASS studies focus on physical limitations,
changes in self-perception, and mild stroke, for those with few to no neurological initially
apparent deficits after large stroke, there are unexplored areas, which require future
investigation. Compared to YASS who do have deficits requiring inpatient rehabilitation,
YASS with acute reversal of symptoms may have different needs post hospital discharge
that are still related to the acute event.
This study aimed to describe how a sample of YASS ages 18-55 years, who
underwent thrombectomy and discharged directly home from the hospital, understand
and perceive their post-stroke symptoms, as well as describe the objective presence or
absence of those symptoms. A quantitative assessment of the YASS perceptions and
beliefs about their symptoms was explored using standard measures for anxiety, fatigue,
depressive symptoms, and stroke specific quality of life. The assessment was guided by
the Common-Sense Model of Self-Regulation which posits that addressing perceptions
about individuals’ symptoms and diagnosis may assist recovery through early
interventions including education and structures for framing individuals’ experiences and
seeking care (Leventhal, Phillips, & Burns, 2016). Understanding YASS new or ongoing
symptoms and how they interpret these symptoms may help with perception of stroke
specific health related quality of life, normalization, recognition and utilization of
resources, and help to mitigate the negative impact these symptoms have on recovery.
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Research Questions
In a sample of YASS ages 18-55 years with first ever ischemic stroke, who received
intravenous alteplase and/or mechanical thrombectomy, had minimal physical deficits (a
score of 0-3 on the modified Rankin Scale) and discharged directly home from the
hospital, using the Common Sense Model:
1) What are the most common symptoms reported by YASS, between one and
eighteen months post-stroke?
2) What are the relationships among clinical variables (NIHSS, mRS), anxiety,
fatigue, depressive symptoms and stroke specific quality of life, in YASS?
3) What do YASS report are the identity, timeline, causes, consequences and
control of post-stroke symptoms of anxiety, fatigue and depression between one
and eighteen months post-discharge?
Specific Aims
1) To describe YASS post-stroke symptoms and how they understand
and perceive their post-stroke symptoms using the Common Sense Model.
2) To examine bivariate relationships between post-stroke symptoms (anxiety,
fatigue, depression, threatening illness perception) and stroke specific quality of
life.
Hypotheses
1) Levels of anxiety, fatigue and depression will be elevated in YASS.
2) Higher levels of anxiety, fatigue, depression, threatening illness perception
will be associated with lower stroke specific quality of life.
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Applying the Common-Sense Model in YASS
This study was guided by the components of Leventhal’s Common-Sense Model
(CSM) of Self Regulation (Leventhal, Philips & Burns, 2016). This model is typically
used to examine how individuals interpret, perceive and respond to their illnesses. Use of
the model assists clinicians in understanding how patients’ illness representations may
predict patients’ response to illness, and to potentially develop interventions to help with
more favorable outcomes (Hale, Treharne, & Kitas, 2007). The components of this model
may be associated with the processes by which YASS perceive, define, and respond to
their acute stroke in the post-discharge environment. Although the acute threat of
physically disabling disease may have passed post-discharge, this study seeks to examine
in the context of this model how it applies to the ongoing self-management of what
symptoms come to represent ongoing health threats.
The model is applicable to acute or chronic conditions, and for this study the
concepts of interest are defined as acute, as perceived physical or cognitive symptoms
(Leventhal et al., 2016). The World Health Organization (WHO) defines acute stroke as a
sudden occurrence of general brain impairment or focal neurological deficits, where
symptoms persist greater than 24 hours and are definitively caused by a vascular event
(World Health Organization, 2017). While ultimately YASS may have their symptoms
reversed through intervention before the 24-hour period, the sudden onset and severity of
the symptoms attributed to vascular disruption are defined here as acute. Symptoms to be
explored in this context include anxiety, fatigue, depressive symptoms, and stroke
specific quality of life.
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Overview and Concepts
The CSM of Self-Regulation describes a dynamic process by which individuals
recognize deviations from their normal functional selves through various stimuli, which
may include physical symptoms, perceived changes, medical diagnoses, discussions with
other individuals, social or mass media, and environmental cues (Leventhal, Phillips, &
Burns, 2016). This input activates a mental representation of an individual’s normal self,
combining previous experiences with illness, how illness was or should be managed and
ultimately of what constitutes an illness threat. These representations are derived through
parallel emotional or subjective feelings and cognitive beliefs (Leventhal, Phillips &
Burns, 2016). The cognitive beliefs are developed through five core constructs or
components that include identity, time-line, consequences, causes and control (Leventhal,
Leventhal & Breland, 2011). If these perceptions are understood by healthcare providers,
they may help to guide mechanisms for identifying YASS at risk for experiencing
anxiety, fatigue, and depressive symptoms, and managing their treatment or recovery.
There is a dual process by which each of the five constructs is both perceptual and
simultaneously representative of possible actions for self-management and/or treatments
(Leventhal, Leventhal, & Breland, 2011). The five core constructs as interpreted in the
context of these YASS are described here.
Identity is the attribution of the symptom or experience to an event such as stroke,
as well as the perceived severity of the threat (Leventhal, Philips, & Burns, 2016).
Examples of the symptoms that may be labeled by the patient include “anxiety” or
“fatigue”. Severity may apply to the ability of the symptom to interfere with functional
recovery.
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Time-line construct is the patient’s understanding of the timing of and the rate at
which the symptoms started, how long he/she experiences them and their decline, if
applicable (Leventhal, Philips, & Burns, 2016). For example, depressive symptoms may
be viewed as short term and something that will resolve in time. Here the individual also
develops a representation of how long treatment may occur and expectations of when
benefits would be observed.
Consequences of symptoms describes both those experienced as well as those
identified as possible, by the patient, and whether they are perceived as serious or not.
These can be physical, cognitive, or psychosocial (Leventhal, Phillips, & Burns, 2016).
For example, after their acute stroke resolves by receiving thrombectomy, some YASS
have reported feeling a disconnect, a slowness of thoughts or not feeling like themselves
(Seagraves, 2017).
Determinants or causes explain to what the patient, who has experienced reversal
of a large stroke, attributes the current symptoms or sensations (Leventhal, Phillips, &
Burns, 2016). For example, YASS may or may not recognize that the symptoms
experienced are potentially ongoing physiological consequences of the acute stroke.
Control is the fifth and final contributor to understanding the health threat. This
refers to the patient experiences, or the belief of whether the experiences, which are a
variation from the normal self, will or do respond to self-management (Leventhal,
Phillips, & Burns, 2016). Perceptions of potential benefits of treatment are also
considered under this domain. According to the CSM, the YASS’ perceptions, as
determined by their representations from the five constructs, may contribute to their
motivation to seek care and to how they cope with their recovery.
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Figure 1. Adaptation of the Common Sense Model in YASS
Anxiety is a concept included in the model. Merriam Webster’s Online Dictionary
(2018) describes the medical definition of anxiety as “an abnormal and overwhelming
sense of apprehension and fear often marked by physical signs (such as tension, sweating,
and increased pulse rate), by doubt concerning the reality and nature of the threat, and by
self-doubt about one's capacity to cope with it”. The presence and levels of anxiety in
YASS in the study were measured using the Hospital Anxiety and Depression Scale
(HADS) (Zigmond & Snaith, 1983). Participants may not identify their symptoms as
signs of anxiety as defined in the selected instrument.
Depressive Symptoms is a concept included in the model. Merriam Webster’s
Online Dictionary (2018) describes the medical condition of depression as inclusive of
the following depressive symptoms: “sadness, inactivity, difficulty in thinking and
concentration, a significant increase or decrease in appetite and time spent sleeping,
feelings of dejection and hopelessness, and sometimes suicidal tendencies”. The presence
and levels of depressive symptoms in YASS in the study were measured using the HADS
(Zigmond & Snaith, 1983). The instrument is designed to identify symptoms, not a
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comprehensive tool for diagnosing depression. Participants may not identify their
symptoms as related to depressive symptoms as defined in the selected instrument.
Fatigue is a concept that is included in the model. Merriam Webster’s Online
Dictionary (2018) describes the medical definition of fatigue as “weariness or exhaustion
from labor, exertion, or stress”. Generally, fatigue is defined as the state of being very
tired or as weariness. The presence and levels of fatigue in YASS in the study were
measured using the Fatigue Severity Scale (FSS) (Krupp et al., 1989).
Quality of life is a concept included in the model as the study examined the
possible relationships among anxiety, fatigue, depressive symptoms, and stroke specific
quality of life. There were twelve domains that were reflected in one of the selected
instruments for this study that in survivors of mild to moderate stroke, through selfreported experiences, may impact the YASS’ quality of life (Williams et al., 1999). The
constructs examined include mobility, energy, upper extremity function,
work/productivity, mood, self-care, social roles, family roles, vision, language, thinking
and personality. The individual sense of well being in the YASS may be related to
anxiety, fatigue, depressive symptoms, and illness perception as they process them
through the five core constructs, and in parallel through emotional/subjective
representations.
Application of the Common-Sense Model
The application of the CSM has expanded over time. Leventhal, Leventhal &
Breland (2010) recognized that the CSM had been used widely in the study of cognitive
function using objective measures but would benefit from the study of the CSM in
examining individuals’ perceptions of their cognitive function and the positive or
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negative impact on their recovery, therefore using subjective measures. The CSM has
more recently been used by researchers to study individuals with mild traumatic brain
injury (MTBI) in the context of their injury beliefs, coping, recovery and outcomes
(Snell, Hay-Smith, Surgenor, & Siegert, 2013). Their study demonstrated that the
components of identity, time-line, consequences, and emotional representations of their
MTBI were associated with reduced functional difficulties over time and that these
patients may benefit from early interventions to change perceptions, specifically related
to setting realistic expectations for recovery time. A study seeking to reduce post-partum
depressive symptoms in African-American and Hispanic women used the CSM as a basis
for an intervention aimed at influencing the five core constructs used to develop their
expectations of the postpartum self (Howell, Bodnar-Deren, Balbierz, Loudon, Mora,
Zlotnik, Wang, & Leventhal, 2013). This intervention guided the women’s
expectations to a realistic representation that subsequently matched the actual feelings
and function experienced by the participants, resulting in a 40% reduction of depressive
symptoms.
Using the CSM of Self-Regulation may help with predicting and interpreting the
presence or absence of alignment between YASS expectations, experiences, and
physiological manifestations post-acute stroke. In order to facilitate use of the CSM, the
Illness Perceptions Questionnaire (IPQ) was developed to assess individual patients’
illness representations (Weinman, Petrie, Moss-Morris, & Horne, 1996). The Revised
Illness Perceptions Questionnaire (IPQ-R) includes an emotional representation subscale, additional symptom coherence items, and additional attributional items in the
causal section (Moss-Morris et al., 2002). This quantitative instrument can be modified to
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ask specific questions on the identity and causal scales regarding beliefs about the
symptoms experienced by YASS. These perceived threats and responses on an
abbreviated version of the instrument associated with the theory, the Brief IPQ, were
compared to clinical levels, as reported on standard questionnaires of anxiety, depressive
symptoms, fatigue, and stroke specific quality of life. The authors of both the original and
revised scales encourage adapting the scales to the individual population of interest, in
this case the YASS who have had a reversal of the devastating physical deficits of acute
stroke, as there may be an association between the way in which an illness, event or
symptom is perceived and the outcomes related to recovery and transition back to their
normal state of health. The constructs may be perceived individually but may be
interrelated. For example, a YASS may be experiencing anxiety which may impact the
ability to sleep, which could contribute to fatigue. Depressive symptoms may inhibit
motivation to participate in social activities, which may impact quality of life.

CHAPTER II
REVIEW OF LITERATURE
Background
This chapter provides a review of recent literature of what is known about the
consequences of stroke in YASS. The different topics explored include common
problems following stroke, such as depressive symptoms, fatigue, and anxiety. Next,
qualitative and quantitative studies of symptoms of YASS, including potential symptoms
impacting return to work in stroke survivors will be described. Additional literature is
examined regarding problems in survivors of minor stroke, including the relationship of
symptoms to quality of life.
The body of knowledge surrounding the consequences of stroke is expansive.
Vast data bases such as the American Heart Association’s Get with the Guidelines
(GWTG) capture pre-hospital to post-acute care outcomes including stroke severity and
level of ongoing disability for stroke survivors (American Heart Association, 2016). The
Centers for Disease Control and Prevention (CDC) report the financial burden of stroke
in the United States as $34 billion annually, which includes the cost of health care,
medications, and lost wages (CDC, 2016). Stroke in the young causes a disproportionate
share of the cost as these individuals are working age and in their productive years
(Smajlovic, 2015). Physical disabilities following stroke often impede return to work,
however, psychosocial factors can also influence return to work and possibly affect
quality and duration of work.
14
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Qualitative Studies of the Experiences of Young Adult Stroke Survivors
Qualitative analyses have captured and categorized the experiences of stroke
survivors across the full spectrum of disability and age (Kuluski, Dow, Locock, Lyons, &
Lasserson, 2014; Lawrence & Kinn, 2012; Martinsen, Kirkevold, & Sveen, 2012; Sadler,
Daniel, Wolfe, & McKevitt, 2014). The studies with participants considered young
included those ages18-62, who ranged from 1.5 months to 12 years post-stroke, with
varying types of strokes, treatments, and disabilities. The subjective experiences of stroke
survivors helped to frame the quantitative design by guiding the researcher’s selection of
concepts and instruments to measure the identified symptoms.
Kuluski et al. (2014) sought to understand experiences of stroke as disabling to
life in their interviews with 17 YASS ≤55 years of age, who were between 1-12 years
post stroke. Using directed content analysis, they found that all 17 YASS experienced at
least one symptom including fatigue, speech and memory impairment, physiological
symptoms and challenges with multi-tasking, from which emerged two main themes of
“altered sense of self” and a “loss of identity”. All of the survivors attributed their
symptoms to their stroke. Similarly, Lawrence & Kinn (2012) interviewed 10 YASS age
18-55 who were three months to two years post stroke. One of their subthemes was
“embodied perception of difference”, which included fatigue, impaired memory, poor
concentration, vision problems and impaired decision-making skills. These survivors
indicated that the cognitive impairments post-stroke were not noticeable when they were
in their home environments but came to light upon return to work. A third group of 22
YASS, ages 20-61, were interviewed to determine the impact of stroke, 6-9 months poststroke, on family life (Martinsen, Kirkevold & Sveen, 2012). The YASS identified
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parenting challenges related to memory loss, slow thinking and absent-mindedness and a
struggle to reintegrate and fulfill the parenting role. Lastly, in their investigation of YASS
navigating the field of stroke care in the United Kingdom, Sadler et al. (2014),
interviewed 31 survivors, ages 24-62 years of age between six weeks and 28 months post
stroke. Two thirds of those interviewed indicated they were still looking for support with
social, psychological and emotional issues. They indicated a need for guidance toward
financial resources and emotional support systems, as they felt isolated and had
challenges coping. A sub-group of five women in the study, with self-reported anxiety
and depression before their stroke, expressed emotional challenges coping with stroke,
including symptoms of crying, mood swings, and depression.
The body of qualitative evidence of post-stroke symptoms in YASS includes a
variety of psychosocial symptoms including fatigue and cognitive changes, and points to
a need for further study of the reported symptoms. The identified symptoms appear to
affect quality of life, returning to work, relationships and parenting. However, these
studies may not include the YASS population of interest, therefore it is important to see if
they experience the same or similar things. The use of quantitative designs with standard
measures may be useful to characterize the level of symptoms and whether the symptoms
are at clinically important levels.
Quantitative Studies of Symptoms in Young Adult Stroke Survivors
Descriptive studies of YASS are widely available and there is evidence of
common sequela of stroke such as the presence of depressive symptoms, fatigue, anxiety
and challenges returning to work, executive dysfunction, and memory problems (Glozier,
Hackett, Parag, & Anderson, 2008; Maaijwee et al., 2014; Naess & Nyland, 2013;
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Sobreiro et al., 2014; Waje-Andreassen, Thomassen, Jususfovic, Power, Eide, Vedeler, &
Naess, 2013; Wang, Kapellusch, & Gaeg, 2012). The following studies describe the
prevalence of post-stroke symptoms experienced by YASS, and with YASS being of
working age, most of the studies also describe the impact of these symptoms on their
ability to effectively return to work.
Naess & Nyland (2013) examined post stroke fatigue and depression and their
role in mortality in a sample of 190 YASS in Norway, ages 15-50 (M=48, SD=9.3). In
this prospective cohort study, the modified Rankin Scale (mRS) was used to assess
physical function, fatigue was evaluated using the Fatigue Severity Scale (FSS) and
depression was assessed using the Montgomery-Asberg Depression Rating Scale
(MADRS). Stroke survivors were followed for 12 years, the mean mRS was 1.3, SD=1.0,
indicating no symptoms or significant disability, but fatigue and depression were
associated with long-term mortality, irrespective of stroke severity. In another study
conducted in Norway, Waje-Andreassen et al. (2013) assessed memory, anxiety,
depression and sleep in a group of 144 YASS age ≤49 years and compared their
symptoms to 167 matched controls, comprised of normal adults matched retrospectively
for age and sex. Their study represented population- based long term follow up at 12
years from onset of stroke and aimed to investigate the above concepts in relation to
functional outcome and full-time work. Like Naess & Nyland (2013) they also used the
mRS to assess function, considering a 0-1 as an excellent outcome. Nearly 71% of YASS
(102/144) had a mRS of 0-1. YASS also completed a questionnaire with yes/no responses
about memory problems, anxiety, depression, sleeping problems, and work. As compared
to 5.4% of controls, 41% of YASS had memory problems. Of those YASS with memory
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problems, only 20.3% worked full time. In YASS versus controls, anxiety was 19%
compared to 9%, depression was 29% compared to13%, and sleeping problems which
can be associated with fatigue was 36% compared to 19% in controls.
Whether a stroke survivor returns to work may be explained by the symptoms
they experience post-stroke. The next three studies describe factors inhibiting return to
work among stroke survivors. Glozier et al. (2008) examined a component of the third
Auckland Regional Community Stroke (ARCOS) study to determine contributors to and
frequency of stroke survivors ages ≥15 years old return to paid work. This prospective
population-based study included baseline interviews with 1423 stroke survivors between
2002-2003, of which 279 (20%) were involved in paid employment at the time of the
stroke, were experiencing their first ever stroke and were cognitively competent to
answer questions independent of a proxy. The Barthel Index (BI) was assessed at oneweek post-stroke as a measure of functional dependence or independence. From this
population, 55 did not survive into the follow-up period. Follow-up telephone interviews
were conducted with the 224 surviving patients, with a mean age of 55 (SD=11), with
169 of the participants completing the General Health Questionnaire (GHQ-28) to assess
psychiatric morbidity, at one and six months after the initial event. The BI scores of those
completing the GHQ-28 were higher than those who did not complete the questionnaire
(M=17, SD=5 versus M=13, SD=8). Psychiatric morbidity, also commonly referred to as
depressive symptoms, was present in 43% of those who were working at six months
compared with 64% in those not working at six months. Thus, the likelihood of returning
to paid work was reduced in the presence of early psychiatric morbidity (OR 0.42; 95%
CI 0.22 to 0.80, p value 0.008).
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In another study examining return to paid work, Andersen et al. (2012) explored
the relationship of fatigue with returning to paid work in a group of 83 first-ever stroke
survivors aged ˂60 years, who were employed full or part time at baseline. Patients were
recruited between 2003-2005 from Arhaus University Hospital in Denmark and were
followed for two years from the onset of stroke. Interviews were conducted with the
stroke survivors at 10 days, three months, one year, and two years after stroke.
Sociodemographic data collected including sex, age and employment status. The Barthel
Index (BI) was used to assess physical function, the Symbol Digits Modalities Test
(SDMT) was used to assess cognitive function, and the Major Depression Inventory
(MDI) was used to assess new onset depression and antidepressant treatment. Fatigue
was the focus of the study thus patients completed a self-rating on the Multidimensional
Fatigue Inventory (MFI-20), which contains four dimensions and a maximum score of
20. A score of ≥12/20 in the dimension of general fatigue was used as the cutoff for
clinically significant pathological fatigue. The percentage of stroke survivors who had
returned to work at least part-time (10 hours minimum) or full-time were 53% at year one
and 58% at year two. Multivariate regression analysis identified fatigue as a strong
predictor of the stroke survivors’ chances of returning to paid work. At baseline, the
adjusted odds ratio (OR) for return to paid work was 0.39 (95% CI 0.16-1.08) for those
with a general fatigue score of ≥12 indicating significant levels of fatigue. At two years
those who still had significant fatigue (≥12) had an OR of 0.29 (95% CI 0.11-0.74).
These results were independent of cognitive deficits and physical disability.
In a comprehensive review of the literature, Wang, Kapellusch, & Gaeg (2012)
examined the results of 42 studies, primarily quantitative, to summarize the factors that
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have been found to influence whether stroke survivors return to work. One of the studies
they included (Wolf, Baum, & Connor, 2009) examined registry data from 7,740 stroke
patients from a single hospital in the United States from 1999-Spring 2008, and found
that 45% of stroke patients were under age 65, and 27% were under age 55, falling into
the working age bracket. Wang, Kapellusch, & Gaeg divided the predictors of return to
paid work from the 42 included studies into 6 categories, which were demographic
variables, body structures, body functions, activity and participation, psychosocial and
other personal factors, environmental factors, and job factors. The body functions
category included subtle cognitive defects, which were only found to be described
qualitatively and thus not statistically examined. These defects included impairment in
multi-tasking, concentration, working memory, mental speed and flexibility, and visualspatial ability. Younger age, higher physical function, family support and white-collar
work were strong predictors of returning to work. Depression was found in 48% of the
individuals included across studies, as determined at stroke follow-up visits, not at the
time of stroke, and was negatively associated with returning to work.
Executive dysfunction, defined as a disruption to the performance of a group of
cognitive processes that regulate and control planning and following through with
activities and goals, has been observed among YASS and examples are provided in the
following studies. Maaijwee et al. (2014) extracted data from the Follow-Up of Transient
ischemic attack and stroke patients and Unelucidated Risk factor Evaluation (FUTURE)
study, which examined first ever stroke patients ages 18-50, admitted to one medical
center in the Netherlands between 1980-2010. Their sample included 160 patients who
had Transient Ischemic Attack (TIA) and 277 who experienced ischemic stroke. YASS
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were matched with 146 stroke and TIA free controls on age. The purpose of this study
was to investigate the long-term prevalence of subjective cognitive failures, and to
investigate the relationship between subjective and cognitive failures and objective
performance. All participants were invited to a follow-up exam in 2009-2010 where they
completed a 15 item semi-structured interview based on the Cognitive Failure
Questionnaire (CFQ), which focused on memory and executive function. Participants
underwent thorough neuro-psychological testing for working memory using the Paper
and Pencil Memory Scanning Test (PPMST), immediate and delayed memory using the
Ray-Osterreith Complex Figure Test (ROCF) and Rey Auditory Verbal Learning Test
(RAVLT). Executive function was tested using Verbal Fluency and Stroop Interference.
The results, while not statistically significant, indicated that subjective memory failures
were present in 86.4% of patients as compared to 67.4% in controls, and executive
failures were found in 67.4% of patients as compared to 41.4% in controls. Conversely,
the only statistically significant association between subjective and objective assessments
was a weak association between subjects’ subjective cognitive failures and objective
immediate and delayed memory performance. It is possible that YASS who receive
mechanical thrombectomy with full resolution of symptoms may meet criteria as TIA
survivors based on pristine neurological imaging post-procedure, if the stroke did not
have time to cause permanent tissue damage. YASS memory and cognitive deficits need
to be addressed by the health care professional, as they may require education, treatment
and coping strategies.
Depression-executive dysfunction was assessed by Sobreiro et al. (2014) in nonelderly stroke patients by examining the association between the retardation domain of
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depressive symptoms and performing poorly on executive function testing. They enrolled
87 participants with a mean age of 50.7 (SD=14.5), with first ever MRI confirmed stroke
and no pre-existing major depression. There was, however, no normal control group
included in the study. Stroke survivors underwent neuro-psychological testing including
the Wechsler Digit Span test, FAS-Spoken Verbal Fluency test, Victoria Stroop test, and
depressive symptoms testing with the Hamilton Rating Scale for Depression (HAM-D31) within the 23-day period post stroke. Results indicated that there was an association
between the fatigue/interest domain of HAM-D-31 with poor performance on the FAS
and on the Stroop Interference (reaction time of a task) in those <60 years of age, which
is consistent with existence of depression-executive dysfunction after stroke in younger
stroke patients.
These above studies describe the presence of a variety of post-stroke symptoms
up to one year in YASS. The presence of actual or perceived physiological symptoms
such as depression, fatigue, anxiety and executive dysfunction appear to impact their
ability to return to paid work and mortality, independent of level of physical disability
and may impact quality of life. These post-stroke complications have not been examined
specifically in the YASS population of interest. These study results indicate a need for
treatment for depression, anxiety, fatigue, cognitive therapy, neurorehabilitation and
neurostimulation in YASS as this syndrome may impact social interaction and return to
work. Long term ongoing challenges are present in previously studied populations of
YASS with excellent functional outcomes, with worse prognosis for memory problems,
anxiety, depression and capacity for full-time employment compared to controls.
Opportunities may exist for early intervention for identification and management of
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depressive symptoms, fatigue and anxiety to increase likelihood to return to paid work
after stroke.
Survivors of Mild Stroke
The phenomenon of mild stroke has been thoroughly evaluated in adult stroke
survivors but infrequently evaluated specifically in YASS. There is strong evidence of
ongoing symptoms related to cognitive deficits, executive dysfunction, depressive
symptoms, depression, anxiety and a significant impact on return to work in adults who
have experienced mild stroke (Altieri et al., 2011; Broomfield, Quinn, Abdul-Rahim,
Walters, & Evans, 2014; Corbetta et al., 2015; de Bruijn et al., 2015; Guajardo et al.,
2015; Hommel et al., 2009; Palmcrantz, Holmqvst, & Sommerfeld, 2014). There is no
scientific consensus as to what defines mild stroke, however it has been defined in the
above referenced studies as smaller infarct size, NIHSS ≤ 3-6, stroke not requiring
intervention or admission to critical care, or by duration of symptoms and physical
disability. Only two studies examining mild stroke had a sample of participants with a
mean age <55 years (de Bruijn et al., 2015; Hommel et al., 2009).
The first study by de Bruijn et al. (2015) examined what stroke-specific medical
and psychological factors may impact the quality of life (QoL) of young ischemic stroke
patients at > 1-year post-stroke. The 170 YASS and 61 non-stroke general controls <57
years of age completed the shortened World Health Organization Quality of Life scale
(WHOQOL-BREF 26), to assess quality of life, the Fatigue Assessment Scale (FAS), to
assess physical and mental fatigue, and the Hospital Anxiety and Depression Scale
(HADS), to assess for depressive symptoms and symptoms of anxiety. Follow-up
telephone calls by investigators assessed the mRS and employment status of the YASS.
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At a mean point of 4.5 years post-stroke, anxiety, depression and fatigue were present in
YASS at 31.9%, 37.2%, and 57.8%, as compared to controls at 17.8%, 6.7%, and 15.9%
respectively. Lower quality of life was associated with higher scores in anxiety,
depression, and fatigue.
In the second study taking place in France, Hommel et al. (2009) assessed social
dysfunction and its contributing factors in 84 first-ever mild to moderate stroke survivors
who were of vocational age, defined as 18-64 years old with a mean age of 43.5
(SD=12.2). These stroke survivors were assessed between three and nine months post
stroke (median 7 months) and had no apparent severe neurological deficits, with an
NIHSS <4, mRS score ≤2 and an MMSE score of at least 23/30 to exclude dementia.
Participants completed the Work and Social Adjustment Scale (WSAS), the HADS and
MMSE (administered by a neuropsychologist), the BDI, and were asked about return to
work at one year. A stroke neurologist ranked the level of disability as having no social
dysfunction, mild to moderate social dysfunction, or severe social dysfunction. Physician
rankings strongly correlated with patient’s self-reported WSAS results, confirming selfperception of dysfunction was reflected in clinical assessments. The mean WSAS was
16.1(SD=10) indicating significant social dysfunction and most participants (68%)
reported a high level of work and social dysfunction that they attributed to their stroke.
Despite the high levels of social dysfunction, survivors had low depression and anxiety
scores and high mental exam scores. Depression results may have been confounded by
the fact that 42% of participants were taking anti-depressants at the time of the analysis.
While mean NIHSS on admission for stroke indicated a mild to moderate event at a mean
of 5.8, the score was down to 0.9 in the NIHSS and mRS 1.4 at the time stroke survivors
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completed the WSAS, indicating almost complete absence of physical or motor deficits.
Indications are that initial stroke severity may have a greater impact on long term social
dysfunction than presence of subsequent physical neurological impairments.
In an older population of 105 survivors of mild stroke, Altieri et al. (2011) sought
to determine the prevalence and predictors of depression over a 30-month time period,
with mild defined as having an NIHSS of ≤5. Participants with a mean age of 64.38 were
enrolled at one hospital in Italy. At one-month post-discharge participants underwent a
standardized neuropsychological assessment for memory, attention, visuospatial function,
executive function, conceptual thinking and language. The Beck Depression Inventory
Short Form (BDI-SF) was used to assess depressive symptoms; however, it was only
administered at the one-month post stroke period. Ongoing depression diagnoses were
made based on the results of the Structured Clinical Interview for the DSM-IV results
using DSM-IV criteria. These were repeated yearly and at 30 months. Forty percent of
stroke survivors exhibited post-stroke depression by the end of the 30-month follow-up
period, and half of these were depressed at the one-month period, with the most frequent
depressive symptoms being work inhibition, indecisiveness, fatigue, sadness and crying.
Broomfield et al. (2014) examined data from a community registry in Scotland for
prevalence of anxiety and depression in a cohort of community dwelling minor stroke
(N=4,079) and TIA survivors (N=1,247) using the HADS score. The median age of the
stroke cohort was 70.3 (IQR=11.3), and the median age of the TIA cohort was 70.8
(IQR=10.9). Investigators found that 29% of participants in both groups had probable
anxiety, and 24% of those with mild stroke and 21% with TIA had scores indicative of
depression. Similar levels of symptoms present between the two groups, those with stroke
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and those with minor stroke or TIA, reflect a need for assessment and possible
interventions for those with mild or reversed symptoms of stroke.
Lastly, Palmcrantz, Holmqvst, & Sommerfeld (2014) examined long-term
functioning and disability and perceived disability in a sample of 150 YASS aged 18-64
years with all types of stroke, against a matched sample in the general population of
Sweden of 2661 individuals free of stroke. Participants completed both the European
Quality of Life- 5Dimensions (EQ-5D), a standardized measure of health, and the
researcher-developed Mapping Young People with Stroke (MYS) questionnaires to
assess self-rated disability between three months to six years post stroke. The level of
stroke was defined as mild in 79% of YASS yet 45% rated their global health as low
compared to 15% of controls. YASS ratings of their global health were lower for those
who reported experiencing symptoms or the presence of perceived deficits in areas such
as tiredness (45%), limits in leisure activities (57%), and work limitations (39%).
Survivors of mild stroke may be the closes to the target population of YASS for
this study. Similar to studies described earlier for survivors of more severe stroke,
outcomes of mild stroke in the studies reviewed included significant levels of depression
and depressive symptoms, anxiety, fatigue, social and work dysfunction and lower
quality of life. The findings of the studies suggest that even survivors of mild stroke need
to be educated, assessed and treated for these complications following stroke.
Quality of Life Following Stroke
Descriptive studies of adult stroke survivors have identified mood symptoms and
psychological consequences of stroke. These common sequalae may impact quality of
life in stroke survivors. For example, Donellan et al. (2010) examined how depression
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and anxiety impact functional recovery and health-related quality of life (HRQoL) in 107
stroke survivors from two hospitals in Ireland, at one-month post stroke and then repeated
at one year. The instrument used to measure anxiety was the Hospital Anxiety and
Depression Scale (HADS). They used the Nottingham Extended Activities of Daily
Living scale (NEADL) to measure functional recovery and to measure HRQoL they
administered the Stroke-Specific Quality of Life scale. Results indicated just over a third
of stroke survivors experienced depressive symptoms and anxiety at one-month post
stroke, and a third also experienced depressive symptoms and anxiety at one year. The
third was not comprised of the same individuals at the two different time points. More
depressive symptoms were associated with poorer functional ability. Higher depressive
symptoms and presence of anxiety were both significantly associated with worse
HRQoL. In a study by de Bruijn et al. (2015) described earlier, anxiety, depression and
fatigue were significantly associated with poorer quality of life in a sample of young
ischemic stroke survivors > one-year post stroke.
The research on quality of life following stroke indicates that anxiety, depression
and fatigue are culprits to lower quality of life. Few studies have examined quality of life
in YASS and none have examined quality of life among the YASS population of interest
or the role symptoms play in explaining quality of life in this population. Identifying
post-stroke symptoms that may be present among YASS is important for understanding
their transition back to self, socialization, work and overall quality of life.
Gaps in the Literature
The body of work described above demonstrates a review of the evidence for the
existence of mood disorders, cognitive deficits including executive dysfunction,
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depressive symptoms, memory problems, fatigue, anxiety, social dysfunction and
challenges returning to work in stroke and TIA survivors, including separate cohorts of
all adult stroke ages and stroke severity, YASS with varying stroke severity and stroke
survivors with mild severity. Limitations include the wide variety of inclusion criteria,
age ranges, study designs including follow-up periods, and instruments used to assess
similar phenomena. Many of the studies were conducted outside of the United States thus
findings may not be generalizable to YASS in the United States. None of the studies
included or differentiated participation of minority or vulnerable populations. Most
studies included at minimum the type of stroke and demographic characteristics of the
participants. Severity of stroke was often categorized, but one striking differentiation was
missing in all but one of the studies: the presenting level of deficit in contrast to the level
of neurological dysfunction upon discharge from the acute setting.
The phenomenon of interest for this proposal considers the YASS with large stroke upon
presentation who subsequently, through intervention albeit medication or mechanical, has
a reversal or major reduction in neurological symptoms. The current literature does not
differentiate these YASS from all other stroke survivors. This emergent population of
individuals benefiting from reversal of large stroke requires investigation to describe the
prevalence of symptoms, their understanding and perceptions of the symptoms, whether
the symptoms relate to health-related quality of life, as well as the measurable
consequences, trajectory of and implications for functional, psychosocial and cognitive
recovery. The study offered an opportunity to explore symptoms in YASS who represent
varying racial and socioeconomic backgrounds.

CHAPTER III
METHODS
Design
This study used a cross-sectional, exploratory design. This non-experimental
approach was selected to facilitate the aims of the study, which were to describe how
YASS recognize, interpret, respond to, and attribute post-stroke symptoms, and to
describe and objectively quantify the presence or absence of anxiety, fatigue, and
depressive symptoms. Relationships among these variables and their relationship to
stroke-specific quality of life were examined. Online surveys using Qualtrics and mailed
paper surveys of the questionnaires were used.
Setting
The study was conducted in the neuroscience department of a large, public,
academic, safety-net hospital in metropolitan Atlanta, Georgia. The patient population of
this hospital is racially diverse however the majority are African American. The patients
are predominantly low income or unfunded. The 900-bed hospital serves acute stroke
patients in a >150 mile catchment area, receiving emergent transfers for stroke treatment
from nearly 70 hospitals, in urban, suburban and rural regions. In 2016, this hospital
treated nearly1200 stroke patients, including 395 patients in the18-55 age range. In 2016,
providers at this hospital performed the highest number of mechanical thrombectomy
procedures for acute stroke of any single hospital in the United States, with 70 of those
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being performed in patients between the ages of 18-55. These patients are seen in the
clinic for follow-up visits after being discharged home from the stroke center, typically
between 1-3 months post-acute stroke. The participants for the study were former
inpatients who were treated in the hospital’s Stroke and Neuroscience Center, which is a
Joint Commission Certified Advanced Comprehensive Stroke Center.
Sample
The target population was young adult stroke survivors (YASS). All patients
treated at the hospital meeting the inclusion criteria were invited to participate. The
inclusion criteria were: 1) ages 18-55 years, 2) received mechanical thrombectomy
treatment for first-ever ischemic stroke, 3) between 1-18 months post-acute stroke at the
time of participation, 4) had a modified Rankin Scale (mRS) score of 0-3 (0-2 indicates
functional independence but clinical documentation was used to determine independence
in conjunction with the documented scale score at discharge) and had been discharged
directly to home from the acute inpatient stay, 5) able to speak and read English, 6)
willing to complete self-administered surveys, and 7) had access to a computer or smart
phone or was willing and able to complete paper surveys by mail or in person at the
hospital. The exclusion criteria were: 1) a history of psychiatric illness such as
schizophrenia or other major depressive disorder, and 2) other major chronic comorbidity such as congestive heart failure, sickle cell disease, advanced (Stage IV)
cancer.
Sample Size
A review was conducted of all patients who received mechanical thrombectomy
in 2016 to determine the available sample and sample size needed to identify the level of
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anxiety, fatigue, depressive symptoms, and SS-QOL, as well as the identity, timeline,
causes, consequences and control of post-stroke symptoms. The review indicated that
57% (N=40) of the YASS discharged directly home after thrombectomy. In 2017 the
annualized trend indicated a similar volume. Therefore, a reasonable number of
participants was determined to be 30 for this pilot study.
Instruments
Data were collected from the medical record and from four self-report instruments
completed by the participants online using the Qualtrics application or on paper.
Demographic and clinical characteristics of the sample were obtained from the medical
record (Appendix A). The variables were age, sex and race; date, type and location of
stroke; treatment modality (intravenous alteplase and/or mechanical thrombectomy);
National Institutes of Health Stroke Scale (NIHSS) score on arrival to the hospital and at
discharge home; and pre-morbid and discharge modified Rankin Scale (mRS) score, two
valid and reliable frequently used measures of stroke disability. The NIHSS is a 15-item
scale that measures stroke-related neurological deficits with scores ranging from 0-42,
where 0 indicates no neurological deficits, ≤6 indicates chances for good recovery and
≥16 indicates severe stroke (Adams, et al., 1999). The mRS measures physical disability
and ranges from 0-6, where 0 indicates no symptoms, 1-5 indicates levels of disability
ranging from no significant disability to severe disability, and 6 indicates death (van
Sweiten, Koudstaal, Visser, Schouten, & van Gijn, J., 1988). Only YASS with discharge
mRS of 0-3 were eligible to participate in the study.
Two additional multiple-choice questions were added by the researcher to assess
participant years of education attained and return to work or student status. Two open-
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ended questions were also included; the first requesting a telephone number should the
student PI need to contact a participant about a questionnaire response, and the second
offering an opportunity for participants to share anything else they would like the
researchers to know about their stroke experience. Existing instruments were used to
measure anxiety, fatigue, quality of life and illness perception via the Hospital Anxiety
and Depression Scale (HADS), the Fatigue Severity Scale (FSS), the Stroke Specific
Quality of Life (SS-QOL) scale, and the Brief Illness Perception Questionnaire (Brief
IPQ) respectively.
Anxiety and Depression
Anxiety and depression were measured using the Hospital Anxiety and
Depression Scale (HADS) (Zigmond & Snaith, 1983) [Appendix B]. The HADS is a 14item tool, divided into two sub-scales, that is used to assess anxiety (7 items) and
depression (7 items). It is a self-report scale for use in non-psychiatric individuals and
requires participant responses to be based on frequency of symptoms over the previous
week. The instrument can be completed in five minutes, and responses are on a 4-point
Likert scale ranging from 0 “not at all”-3 “very often indeed” based on the frequency of
occurrence. Sub-scale totals range from 0-21 and are reported separately for anxiety and
depression. Items are summed and scores of 0-7 are considered normal, 8-10 are
considered borderline abnormal, and 11-21 are abnormal. These ranges were validated in
a general outpatient population sample-(N=50), aged 16-65 years, for anxiety with a cutoff of 8: specificity=0.78, sensitivity=0.90 and for depression with a cut-off of 8:
specificity=0.79, sensitivity=.083 (Zigmond & Snaith, 1983). Woolrich, Kennedy, &
Tasiemski (2006) evaluated the HADS in a sample of 963 community dwelling
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individuals in the United Kingdom, with varying levels of spinal cord injury. Their mean
age was 48.1 years (SD=12.7; range 20–97) and 81% of the sample were male. The mean
age at the time of injury was 28.6 years (SD=9.2; range 18–50) and the mean time since
injury was 19.5 years (SD=12.26; range 2–56). Researchers performed a factor analysis
and found a two-factor solution approximating anxiety and depression. Internal
consistency was evaluated and for the anxiety sub-scale, the Cronbach’s alpha was .85,
and for the depression sub-scale, the Cronbach’s alpha was .79 (Woolrich, Kennedy, &
Tasiemski, 2006). A literature review of 747 published papers using HADS (Bjelland,
Dahl, Haug & Neckelmann, 2002) demonstrated HADS was effective in assessing
symptom severity and caseness of anxiety disorders and depression in a wide variety of
clinical conditions, and in the general population.
Fatigue
Fatigue was measured using the Fatigue Severity Scale (FSS) (Krupp et al., 1989)
[Appendix C]. The FSS is a self-reported questionnaire used to assess the level of
debilitating fatigue impacting function in all individuals, but more specifically was
developed for and has been validated in a number of neurological disorders. The
instrument contains nine questions, with responses on a 7-point Likert scale that ranges
from 1 “strongly disagree” to 7 “strongly agree” (Krupp et al., 1989). Lower scores
indicate lower fatigue severity. The questions are designed to be answered by participants
based on frequency of symptoms over the previous week. The FSS can be scored
obtaining a sum or an average of the items. In the early use of the FSS items were
summed with total scores ranging from 9-63. A score of >36 was considered to be severe
fatigue and indicated a need for further evaluation (Krupp et al., 1989). However, a recent
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review of the literature revealed a more frequent use of calculating scores to obtain an
average score (i.e. dividing the summed score by 9) ranging from 1-7 where a score of ≥4
indicates severe fatigue (Learmonth et al., 2013). The latter method was used in the
study.
In a sample of Multiple Sclerosis (MS) patients (N=82), test-retest reliability of
the FSS at six months (moderate at 0.75), precision (0.7, mean=5.1 points meaning a
change of ˂0.7 points may be due to error), and clinically meaningful change (change in
1.9 points on mean score necessary to reflect change) were demonstrated. Construct
validity of the FSS was established with the Modified Fatigue Impact Scale (MFIS), with
a Spearman correlation >.05 indicating a moderate relationship amongst all variables
(Learmonth et al., 2013). Reliability and validity were also established in a sample of
persons with spinal cord injury. For reliability the Cronbach’s alpha was .89 and the testretest Interclass Correlation Coefficient was .84, indicating adequate reliability. Construct
validity was established (Pearson correlation r=0.67) with the Visual Analog Scale for
Fatigue (VAS-F) and (r=0.58) the Center for Epidemiologic Studies Depression Scale
(CES-D) (Anton, Miller, & Townson, 2008) indicating the FSS performed as
hypothesized in direction and magnitude. The FSS also has been validated in a sample of
individuals following stroke, helping to establish the utility of the scale in capturing the
phenomenon of interest in the post-stroke patient population. When stroke patients
(n=257) were matched with healthy individuals and measured at three months post-stroke
using the FSS with a cutoff score of ≥4, stroke patients were found to have fatigue
severity (above the cutoff score) prevalence of 31.1% as compared to the matched group
prevalence rate of 10.9%. Participants also completed the fatigue question of the
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HUNT3-survey and had similar results, indicating criterion validity of the FSS (Egerton
et al., 2015). Overall the FSS has been established as a reliable and valid tool to measure
the severity of fatigue.
Health Related Quality of Life
Health related quality of life is a multidimensional construct and was measured by
the Stroke Specific Quality of Life (SS-QOL) scale (Williams et al., 1999) [Appendix D].
The SS-QOL scale is 49-item questionnaire that is comprised of 12 domains, and divided
into sub-scales which include energy, upper extremity function, work/productivity, mood,
self-care, social roles, family roles, vision, language, thinking, and personality (Williams,
et al., 1999). The questions are designed to be answered by participants based on their
experiences over the previous week. The items are scored on a 5-point Likert scale,
ranging from 1 = “strongly agree” to 5 = “strongly disagree” with higher scores
indicating better quality of life. The lowest total score possible, indicating poorer quality
of life, is 49, and the highest is 245. Scores can be calculated for individual domains or
for the entire scale.
The 12 domains of the SS-QOL subscales demonstrated high reliability with all
domains’ Cronbach’s α values ≥0.73 (Williams et al., 1999). In order to develop the SSQOL scale, stroke survivors (N=34) were interviewed by a single investigator at one and
6 months post-stroke. Common domains were identified from the interviews as well as
from review of other stroke and health related quality of life instruments (Williams et al.,
1999), inductively establishing content validity. Once fully developed, the instrument
contained 12 domains, and was then used by the same researchers in a different study
cohort (n=72) of patients with mild to moderate stroke, at one and three months post-

36
stroke. Patients were administered the SS-QOL as well as the (SF-36) Barthel’s Index
(BI), Beck Depression Inventory (BDI), and the Short Form 36 (SF-36) to measure
construct validity of the 12 domains (Williams et al., 1999). Construct validity was
established by comparing the linear association of each domain score with the score of
one of the above established outcome measures. Most overall domains in this initial study
demonstrated reasonable construct validity. After this initial study, individual items were
retained if they were responsive to patient-reported change, resulting in the 49 items used
currently.
Perception of Symptoms
Perception of symptoms is a person’s understanding of the different dimensions
of symptoms he/she is experiencing. The Revised Illness Perceptions Questionnaire
(IPQ-R) is an instrument that was developed for use with the Common Sense Theory of
Self-Management (Moss-Morris et al., 2002). The IPQ-R evaluates individuals’
perceptions of symptoms and whether they believe the symptoms are related to an illness,
which in this case is stroke. Researchers are encouraged to change the wording of items
by changing “illness” to the subject of interest, in this case stroke. The scoring can be
divided into eight subscales. The first subscale is Identity, represented by 12 items, in
which participants reply “yes” or “no” to whether they have experienced a list of
symptoms and then “yes” or “no” if they believe the symptoms experienced are related to
their stroke. Next are Timeline acute/chronic (6 items), Consequences (6 items), Personal
control (6 items), Treatment control (5 items), Illness coherence (5 items), Timeline
cyclical (4 items), and Emotional representations (6 items), which are all scored on a 1-5point Likert scale, varying by subscale, with some reverse scored individual items. For
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example, 1 indicates “strongly disagree” and 5 indicates “strongly agree” in the Identity
subscale. The last section, Causes, (C1-C18), which is not considered a subscale, assesses
participants’ subjective views about what might be the possible causes of their illness, in
this case, stroke. These final 18 questions are coded as causes and are also scored on a 5point Likert scale, from 1 “strongly disagree” to 5 “strongly agree”. Participants are also
asked to rank order the three most important factors they believe caused their symptoms.
High scores on identity, timeline acute/chronic, consequences and timeline
cyclical correspond with strong beliefs about how many symptoms participants feel are
related to their stroke, are chronic symptoms, are negative consequences of their stroke
and are cyclical in nature. High scores on personal and treatment control and illness
coherence, indicate that participants feel they can control their symptoms and that they
have a stronger personal understanding of their condition.
The IPQ-R was validated using eight illness groups (Moss-Morris et al., 2002).
Factor analysis was used to validate the factor structure of the 50 items in Part II of the
instrument using two separate principal component analyses (PAS). This first PAS
produced 11 factors. The remaining 38 items loaded onto 7 factors of greater than 0.5.
Nearly all individual items loaded exclusively onto one of the 18 factors. For instrument
reliability Cronbach alpha coefficients were calculated for each subscale and ranged from
0.79-0.89. Another PAS was conducted on the 18 causal items and it indicated four
distinct factors; Psychological attributions, Risk factors, Immunity, and Accident or
Chance. Cronbach’s alphas on these factors ranged from 0.67-0.86. The Positive and
Negative Affect Schedule (PANAS), an instrument that measures a person’s enthusiasm,
activity and alertness, and subjective distress and discomfort, was used to determine

38
discriminant validity using Pearson’s correlations between the subscales of the IPQ-R.
Correlations were mostly small or moderate with the largest being between the Emotional
Representations Negative Affect (r=.54) (Moss-Morris et al., 2002). Correlational
analyses were also performed with The Ambulatory Index, Sickness Impact Profile (SIP),
and FSS to assess predictive validity and results demonstrated that most dimensions were
significant predictors of the IPQ-R (Moss-Morris et al., 2002). Test-retest reliability was
assessed as part of the study validating the IPQ-R, by administering the IPQ-R a second
time to participants in the rheumatoid arthritis illness group six months after the first.
Nearly all correlations were >.5. It was also tested at a three-week interval in the renal
dialysis group. Of the 12 subscales only one correlation was <.5 at .46 and values ranged
from .46-.88 (Moss-Morris et al., 2002).
A shorter, self-administered version of the IPQ-R, the Brief Illness Perception
Questionnaire (Brief IPQ) was developed to enable rapid assessment of cognitive and
emotional representations of illness (Broadbent, Petrie, Main, & Weinman, 2006)
[Appendix E]. Participants completed the Brief IPQ. It was designed to be more useful
when measuring illness perception as part of a larger group of psychosocial concepts.
Each of the eight subscales from the IPQ-R are represented by one question on the Brief
IPQ and are measured on a 0-to-10 response scale. Items 3, 4, and 7 are reverse scored.
Higher scores reflect a more threatening view of the symptoms. A ninth item corresponds
to the causal representation question, asking patients to list what they perceive to be the
three most important factors causing their illness, or in this case, symptoms.
Psychometric properties of the Brief IPQ were evaluated using data from six
illness groups (Broadbent, Petrie, Main, & Weinman, 2006). Test-retest reliability was
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established at 3-week and 6-week intervals, with Pearson correlations in all eight
domains P<.001 at 3-weeks and P<.001 in seven of the eight domains at 6-weeks.
Concurrent validity was assessed in three of the illness populations using correlations
between the IPQ-R and the Brief IPQ, with results indicating the scales are appropriately
correlated. Predictive validity was investigated in the Myocardial Infarction (MI) illness
group, which is similar to stroke in the nature of sudden onset of symptoms and available
treatments. A MANOVA was performed and the Brief IPQ was predictive of five
domains at discharge in MI patients and mental and physical ability at three-month
follow-up: consequences, identity, concern, emotional response, and treatment control.
Procedures
After obtaining IRB approval and a partial HIPPA waiver to enable screening of
potential participants, the researcher reviewed a total of 22 months of closed inpatient
medical records of YASS who received care at the Stroke and Neuroscience Center of the
selected hospital. Once deemed eligible based on medical record review potential
participants were contacted. They were contacted by telephone, email, and/or United
States Postal Service mail between 1-18 months post-discharge. Text messaging was used
when contacted by telephone, in which the student principal investigator (PI) informed
potential participants about the study and ascertained their interest in participating. If they
were interested, the research procedures were emailed to the potential participant. When
contacted by email or postal service the first page informed potential participants about
the study. Participants had an opportunity to ask questions about the study as needed at
the initial contact and throughout the study. They were informed that their participation
was voluntary and they could withdraw from the study at any time without penalty
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including accessibility to and quality of healthcare at the Stroke and Neuroscience
Center.
Prior to the start of the study, the four questionnaires were entered into Qualtrics
and reviewed with a member of the dissertation committee for accuracy and
functionality. They were then completed by three YASS to validate their clarity and the
time required to complete them. Typographical and formatting errors were corrected prior
to sending the Qualtrics link to participants. For those individuals identified as meeting
inclusion criteria with an email address in the medical record (n=15), emails including a
link to the Qualtrics surveys were emailed at 1-18 months post-discharge with a reminder
email sent two weeks and one and two months after the first email contact as needed.
Additionally, seven email addresses were provided by participants who responded to
texts and requested the electronic format. The first link on the opening page of the email
was the study consent form. The second link on the opening page of the email was the
Qualtrics application with the survey. The language in the consent form indicated that by
completing and returning the surveys they were consenting to participate. Additionally, a
hard copy of the study information and survey was mailed to all potential participants
with a pre-address stamped envelope to return the surveys to the student PI. Paper
surveys were numbered to match emailed surveys by potential participants, in order to
prevent any duplication should a participant complete both the paper and electronic
surveys.
Once participants completed the online or paper surveys, their responses were
reviewed by the PI for accuracy and for reported symptoms. A contact telephone number
for the participant was requested on the survey in order discuss any missing or discrepant
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data, and to inform participants of high scores suggesting follow up with their physician.
After completion of the surveys, participants received a personal handwritten thank you
letter with a $20 gift card. This was mailed to participants at their self-designated best
address. The total time for participation in the study including survey completion was
estimated at 30 minutes.
Data Analysis
All data were entered in IBM SPSS Statistics version 25 database for the data
analysis. Demographic data from participants’ medical records were entered into SPSS
by the researcher. Data collected in the Qualtrics program were transferred to SPSS and
data from paper responses were entered into SPSS by the researcher. Prior to statistical
analysis, all data were reviewed to check for errors and missing values. Errors were
corrected and missing values were addressed. Data were also checked for normality to
identify outlying or extreme observations. None were identified. Descriptive statistics
were performed to describe the characteristics of the sample and the major study
variables. Measures of central tendency were reported for the demographic and medical
characteristics of the sample, as well as the standard questionnaire responses. Spearman’s
correlations were performed to determine bivariate relationships among anxiety, fatigue,
depression, illness perception and stroke specific quality of life. Open ended question
responses were evaluated for common themes, and grouped accordingly into four
response categories.
Human Subjects Protection
The study proposal was submitted to the Institutional Review Board at Georgia
State University and the Nursing Research Oversite Committee (ROC) at the recruitment
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site, which is a large, public, academic, safety-net hospital in the Southeastern United
States, for approval prior to study implementation. Informed consent was obtained by all
study participants [Appendix F] Strategies were undertaken to maintain confidentiality of
participants and their data. In addition to the process for consent and enrollment
discussed previously, a unique identification number was used on all forms and the list
with participant information and matching unique identification number was stored in a
locked cabinet in a secure office of the PI. This information was kept separate from the
associated data. Data were stored on a password protected secure computer in a password
protected file. Individual contributor information was not contained in the same files as
the data. When disseminating the findings of the study, the data will be reported in
aggregate.
This study involved assessment of the symptoms of psychological illness which
may require follow up health care. The consent form included a statement that if high
scores were identified for significant symptoms related to anxiety, depression or fatigue
participants would be informed by the PI and encouraged to follow up with their primary
care provider or neurology post-acute care provider.
Based on the historical population at the enrollment site, all genders were
included in the study. Minority populations were significantly represented as they have
represented nearly 75% of the annual stroke patient volume at this large, public,
academic, urban hospital. Children were not included in the study as the population of
interest is adults aged 18-55. Pregnant women were not included in the study.
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Special Planning and Safeguard Strategies
While this study population does not fall into a traditionally recognized vulnerable
population such as pregnant women, children, fetuses, or prisoners, as mentioned above,
the NIH does include individuals with neurologic diseases, including stroke, to
potentially have questionable capacity to provide informed consent (NIH, 2009). The first
special consideration for this study was to consider carefully the cognitive capacity of the
YASS to consent and to participate in the study. Blackmer (2003) addresses this concern
in the rehabilitation medicine population, and speaks specifically to stroke, as it is the
most common diagnosis in this arena. He purports that while many of these patients
recover neurologically, judgement and reasoning may be impaired and thus they may not
truly be informed regarding participation. He suggests these individuals undergo
additional capacity assessment. To address this in the study, the inclusion criteria helped
to minimize the possibility that at the time of recruitment prior to or soon after discharge,
these YASS were incapable of decision making. To be considered for participation, they
had to be discharged directly home and have had no appreciable neurological deficits
with a mRS of 0-3 and a low NIHSS score. Cognitive screening was a part of the
standard assessment and treatment of a stroke patient in a Comprehensive Stroke Center,
and the recruitment site is a certified Joint Commission Comprehensive Stroke Center
(Facts about Comprehensive Stroke Center Certification, 2017). Confirmation of a
negative cognitive screen indicating no impairment was included in the record review for
eligibility before approaching potential participants.

CHAPTER IV
RESULTS
The results of this cross-sectional, exploratory study of the presence of
psychosocial symptoms in young adult stroke survivors post-acute thrombectomy for
ischemic stroke are presented in this chapter. A summary of the characteristics of the
sample, responses to the study aims, hypothesis testing, and research questions are
reported.
Figure 2 demonstrates the screening and enrollment data. There were 80 potential
participants identified through the initial screening process of medical record review of
all acute strokes presenting to a large, public, academic, safety-net hospital
comprehensive stroke center in the southern United States, from January 2017 through
October 2018. Of these YASS, 38 (48%) did not meet eligibility criteria, with the
majority being excluded for major medical comorbidities, followed by being non-English
speaking then death. Of the 42 participants who met eligibility criteria, a total of 14
participants were enrolled in the study. Of the remaining 28 who were not enrolled,
three declined with no reason, one declined after agreeing to participate but then denied
having had a stroke, one returned the questionnaires but was outside the window for
eligibility, and two agreed to participate but never completed the questionnaires. Based
on the contact information available for each potential participant, attempts were made to
contact them, but of the remaining 21 potential participants, four sets of questionnaires
were returned as undeliverable by the United States Postal Service, one text response
44
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indicated the telephone number did not belong to the potential participant, and the
remaining 16 did not respond to three emails, one postal mailing, and two-three telephone
texts regarding study participation. It is unknown whether the contact information
provided in the medical record was accurate as it is common for false numbers and
addresses to be given at the time of hospital registration.

Potential participants screened for
enrollment in the study (n=80)
↓

Not Eligible/Excluded n=38 (48%)







Chronic severe CHF (n=14)
Previous stroke (n=8)
Stage IV cancer (n=4)
Major depressive disorder (n=2)
Non-English Speaking (n=7)
Deceased (n=3)

↓

Eligible n=42 (53%)
↓

Non-participants n=28 (67%)
 Unable to reach (n=16)
 Declined (n=6)
 Incorrect contact
information (n=5)
 Responded outside
eligibility window (n=1)

↓

Eligible participants enrolled
n=14 (33%)

Figure 2. Screening and Enrollment for Young Adult Stroke Survivor Study
Demographic characteristics of those who were eligible but did not participate (n
= 38) were nearly identical for race (Black 61%, Caucasian 29%) compared to those who
did participate, with the exception of three with unknown race and no potential
participants identified as Asian. The mean age of non-participants was 47.6 (SD=7.8)
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which was similar to the study population with a mean age 45 (SD=6.2). However, the
non-participants were 64% male, as compared to only 29% male in the study sample
Data Entry & Screening Procedures
Data were collected electronically from 12 of the participants, using the Qualtrics
application, and two participants who completed and returned paper surveys. Data
collected in the Qualtrics program were exported to SPSS and data from paper responses
were entered into SPSS by the student investigator. Prior to statistical analysis, data were
reviewed to check for errors and missing values. Errors were corrected, and missing
values were addressed. Of the 14 participants, 12 completed all questionnaires with two
having missed a single item on a questionnaire. As the questionnaires require information
about the participants’ experiences over the past week, they were not contacted due to the
time delay from original data collection. Two participants completed only the first
questionnaire, the HADS, however those responses were complete for the major variables
of anxiety and depression and therefore included in the study. One participant omitted
one of six questions on the motor subscale of the SSQOL and the case mean substitution
method was used for mean item replacement to populate the variable. There was also one
missing response omitted by a participant for the treatment control item of the Brief IPQ.
As each question on the Brief IPQ represents a domain, this domain could not be
calculated. However, the other items in the questionnaire for that participant remained in
the data for individual domain scoring but were not included in the Brief IPQ total score
variable for this participant.
Data were also checked for normality to identify outlying or extreme
observations. Descriptive analysis was performed to determine normality of categorical
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and continuous data variables, including measures of central tendency, skewness and
kurtosis, with no abnormalities identified. Major variables under consideration included
anxiety, depressive symptoms, fatigue, SSQOL and illness perception.
Characteristics of the Sample
The sample included 14 participants, with a mean age of 45 (SD = 6.2) years,
ranging from ages 34-52 years. Women outnumbered men 2.5:1, and the majority of
participants were African American/ Black (n = 8), with the remaining sample comprised
of Caucasians (n = 4) and Asians (n = 2). Of the 12 participants reporting on years of
education, 25% did not complete high school, 8% completed high school with no college,
25% completed a two-year college program, 33% earned a four-year college degree and
8% completed a PhD program. Participants were between 4-18 months (M = 12.5) poststroke at the time of study participation. There were 43% in the 0-6 month range, 36% in
the 7-12 month range, and 21% between 13-18 months post-stroke. Of the 11 participants
reporting on return to work or school, seven were back at work full time, two were back
part time, and two reported that they were not employed at the time of stroke.
Clinical characteristics are presented in Table 1 and were normally distributed.
Nearly half received IV alteplase prior to thrombectomy, had an occlusion in the M1
MCA, and all had clinically optimal recanalization of the artery (TICI 2b or 3). The premorbid mRS scores were zero for all participants and the discharge mRS was evenly
distributed (0-3) across this sample indicating equal representation of varying levels of
independent function.
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Table 1
Sample Clinical Characteristics of YASS Participants (N=14)

Characteristic
Premorbid mRS

N (%)

M (SD)

0(100)

Discharge mRS

1.4(1.2)

0

4(29)

1

3(21)

2

4(29)

3

3(21)

Arrival NIHSS

10.9(6.2)

Discharge NIHSS

2.0(2.6)

Received alteplase

6(43)

Clot location
M1 MCA

7(50)

MS MCA

4(29)

ICA

1(7)

ICA Terminus

1(7)

UTD

1(7)

(Table 1 Continues)
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(Table 1 Continued)

Characteristic

N (%)

M (SD)

TICI score
Grade 2b

5(36)

Grade 3

9(64)

mRS=modified Rankin Scale Score, NIHSS=National Institutes of Health Stroke Scale,
MCA=middle cerebral artery, ICA= internal carotid artery, UTD=unable to determine,
TICI= Thrombolysis in Cerebral Infarction Scale with 2b and 3 being successful
reperfusion
Reliability of Instruments
As previously stated, there were four questionnaires used to gather data from the
participants in this study: the HADS, FSS, SS-QOL, and the Brief IPQ. Reliability testing
for internal consistency was calculated for each questionnaire including item-level
statistics and reported using Cronbach’s Alpha. The alpha coefficients for the instruments
are reported in Table 2.
Table 2
Descriptive Statistics and Cronbach’s Alpha of the Major Variables

Actual
Possible
Min-Max Min-Max

Cronbach’s
Alpha

n

M

SD

Anxiety
(HADS)

14

4.57

3.39

1-13

0-21

.69a

Depression
(HADS)

14

4.43

3.63

0-12

0-21

.72

(Table 2 Continues)
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(Table 2 Continued)

Fatigue
(FSS)
Quality of
Life
(SSQOL)
Illness
Perception
(Brief IPQ)

Actual
Possible
Min-Max Min-Max

Cronbach’s
Alpha

n

M

SD

12

4.00

1.91

1-7

1-7

.95

12

185.67

44.47

110-243

49-245

.97

11

30.73

15.93

12-68

0-80

.63

a. When total HADS instrument reliability calculated including depression and anxiety,
Cronbach's Alpha is .84

Descriptive Statistics of Major Study Variables
The major study variables described in this section are anxiety, depressive
symptoms, fatigue, SSQOL and illness perception. Descriptive statistics for each variable
are presented in Table 2.
The HADS literature purports that anxiety and depression are not present if the
subscale score is ≤ 7, borderline if between 8-10, and definite for scores >10, with
potential scores between 0-21. For the anxiety component, this sample had one borderline
(subscale score = 10) and one definite (subscale score = 13) case. For the depression
component, there were three borderline cases (subscale scores = 8,8,9) and one definite
(subscale score = 12) case. For the FSS, clinically significant fatigue is represented by a
score ≥ 4, and 42% (n = 5) of participants had a score ≥ 4. There were three borderline
cases of fatigue (scores = 3.3, 3.4, 3.6).
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Total SS-QOL scores can range from 49-245, with higher scores indicating better
quality of life. The total mean score for this sample was 186 (SD = 44). This mean is
below the midpoint of the scale. Subscale scores can range from 1-5 with higher scores
also indicating higher quality of life (Table 3). Two subscale domains, personality (M =
2.89) and thinking (M = 2.92), fell below the midpoint of the scale. Descriptive statistics
for the SS-QOL subscales are presented in Table 3.
Table 3
Descriptive Statistics of Stroke Specific Quality of Life (SSQOL) Subscales (n = 12)
Subscale Domain

M

SD

Personality
Thinking
Social roles
Energy
Language
Family
Mobility
Mood
Work/productivity
Upper extremity
Vision
Self care

2.89
2.92
3.15
3.47
3.48
3.72
3.76
3.80
4.28
4.38
4.53
4.78

1.45
1.38
1.29
1.34
1.30
1.20
1.31
1.17
1.03
1.02
0.66
0.57

Actual
Min-Max
1-5
1-5
1-5
1.3-5
1-5
1.7-5
1.7-5
1-5
1.7-5
1.4-5
3-5
3-5

The Brief IPQ scores can range from 0-80 with higher scores indicating a more
threatening view of the illness. This mean score among this sample was 30.7 (SD=15.9),
which was below the midpoint of the scale. However, when looking at the individual
items representing the domains on a 0-10 scale, four domains ranged from 4.08 to 4.42.
These individual domain scores indicate a moderate threatening illness perception of the
consequences, treatment control, concern and emotion domains. Descriptive statistics for
the Brief IPQ domains are presented in Table 4.
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Table 4
Descriptive Statistics of the Brief Illness Perception Questionnaire (IPQ) (n = 12)
M

SD

Actual
Min-Max

Consequences: How much do your symptoms affect your life?

4.42

2.91

0-8

Timeline: How long do you think your symptoms will continue?

3.25

3.49

0-10

Personal Control: How much control do you feel you have over
your symptoms?

3.67

3.03

0-10

Treatment Control*: How much do you think your treatment
can help your symptoms?

4.27

3.98

0-10

Identity: How much do you experience symptoms from your
stroke?

3.50

3.32

0-10

Concern: How concerned are you about your symptoms?

4.25

3.19

0-10

Emotional Representation: How much do your symptoms
affect you emotionally (do they make you angry, scared, upset or
depressed)?

4.08

3.34

0-10

Coherence: How well do you feel you understand your
symptoms?

2.67

2.31

2-10

Domain

*(n = 11)
Research Questions
Research Question 1: What are the most common symptoms reported by
YASS, between one and eighteen months post-stroke?
Based on the three targeted psychosocial variables (i.e. anxiety, fatigue and
depression), fatigue was the most prominent symptom reported. Five participants were
experiencing clinically significant fatigue, while fewer were experiencing clinically
significant anxiety (n =1) or depression (n = 1).
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Participants listed in rank-order the three most important factors they believe
caused their symptoms. This question was answered by 78% of participants. Possible
contributors to fatigue were also observed in these responses. Participants reported
medications (n = 3) as the cause, functional items (i.e. fatigue, sleeping habits, too much
or hard work) (n = 5), and poor self-care (n= 4), including eating habits, not taking care
of body, and too long standing. Participants also described physiological symptoms that
included eye sight changes (n = 1), cognitive (memory) issues (n = 1), numbness of the
face and arm (n = 1), “vein had a dent” (n = 1), flu (n = 1), and weakness (n = 1). Only
three participants indicated that stroke caused their symptoms.
Lastly, there was one open-ended question where participants were asked to share
anything else that they would like the student researcher to know about their stroke
experience. Six of the 12 participants included a response for this question. Responses are
categorized in Table 5.
Table 5
Stroke Experience Comments Categorized

Physical
“A slow start”
“Too fast”

Religious Faith
“I’m a Christian,
and I believe I was
healed with the
grace of God”

Gratitude
“I believe I was
very lucky to have
such an attentive
team”

Education
“I don’t believe I
was educated well
enough on what
happened to me”

(Table 5 Continues)
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(Table 5 Continued)

Physical

Religious Faith

Gratitude

Education

“Always trying to
push forward”
“Trying hard”

“I want to suggest
that you may think
about the influence
of faith on stroke
patients”

“Everyone worked
quickly starting
from my daughter
calling 911”

“Once I got home
and back to work, I
realized things were
not back to normal”

“Hot spot rear of
head Loss of sightperipheral vision
left eye”

“God is good…”

“…and so is
Grady’s stroke
unit”

“There is a
difference in what
information the
doctors think is
important versus
the patient”

“Stroke on right
side of body”
“Memory is gone”
“Fatigue”
“Shortness of
breath”
“Headache
Migraines”

“Uneducated in this
and not being able
to search online,
read, process, etc.”

“Right side motor
skills not as strong
as left”

Research Question 2: What are the relationships among clinical variables
(NIHSS, mRS) anxiety, fatigue, depressive symptoms and stroke specific quality of life,
in YASS?
The relationships among these variables were examined using Spearman’s rho
correlations and the data are presented in Table 6. The nonparametric Spearman’s rho
was calculated, due to the small sample size of 11-12, and rs values ranged from -.623 to
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.735. The correlation analysis was for exploratory purposes and the results should be
interpreted with caution due to the small sample size (Polit, 2010).
There were no significant relationships (p>.05) identified between clinical
variables, including discharge mRS scores (rs values ranged from -.237 to .288) and
arrival NIHSS scores (rs values ranged from -.196 to .376) and the primary psychosocial
variables of interest. However, there were significant correlations found among the
psychosocial variables examined. There was a significant relationship between anxiety
and depression, with increased anxiety associated with increased depression. However,
anxiety and depression were not related to fatigue and illness perception was not related
to anxiety, depression or fatigue. Anxiety, depression, and fatigue scores were found to
have an inverse relationship with SSQOL. Higher anxiety, depression and fatigue were
associated with lower SSQOL. Additionally, greater perceptions of the threat of
symptoms (higher score means more threatening view) were associated with lower
SSQOL. Overall the findings were consistent indicating the more severe the psychosocial
symptoms, the lower the SSQOL.
Table 6
Relationships among Major Study Variables
Measure
1. Quality of Life

1
−

2
-.65*

3
-.74**

4
-.73**

5
-.62*

2. Anxiety

-.65*

−

.68**

.19

.47

3. Depression

-.74**

.68**

−

.50

.26

4. Fatigue

-.73**

.19

.50

_

.38

5. Illness Perception

-.63*

.47

.26

.38

−

*. Correlation is significant at the 0.05 level (2-tailed).
**.Correlation is significant at the 0.1 level (2-tailed).
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Research Question 3: What do YASS report are the identity, timeline, causes,
consequences and control of post-stroke symptoms of anxiety, fatigue and
depression between one and eighteen months post-discharge?
The Brief IPQ captures the subscales of the Common Sense Model, and the
results of the eight subscales are reported in Table 4. Scores of zero indicate no threat of
the symptoms while scores of 10 indicate a highly threatening view of symptoms. The
mean response in four of the items (i.e. consequences, treatment control, concern, and
emotional representation) was >4, indicating a moderately threatening perception of those
domains. None of the items on the Brief IPQ had a mean score of zero, indicating that in
all domains there was some perception of threat from their post-stroke symptoms.
Hypothesis Testing
Hypothesis 1: Levels of anxiety, fatigue and depression will be elevated in YASS
This hypothesis was tested using the HADS and the FSS to screen for levels of
anxiety, depressive symptoms and fatigue. Elevated was defined according to
questionnaire cutoff scores. When using the criteria associated with these instruments, the
HADS results indicated only one each of definite cases of anxiety and depression, and the
FSS indicated that five (42%) participants had severe fatigue.
Hypothesis 2: Higher levels of anxiety, fatigue, depression, and illness threat
perception will be associated with lower stroke specific quality of life.
This hypothesis was tested by performing Spearman’s rho bivariate correlations
between psychosocial variables (i.e. anxiety, depression, fatigue), and SSQOL.
Statistically significant results were observed that indicated strong correlations between
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each psychosocial variable and SSQOL, such that higher anxiety, depression, fatigue, and
illness threat perception were associated with lower SSQOL.
Summary
Chapter IV has presented the results of this non-experimental, cross-sectional,
exploratory study to examine relationships among clinical and demographic
characteristics, psychosocial variables and quality of life in YASS who were treated with
intravenous alteplase and/or mechanical thrombectomy, had minimal physical deficits
and were discharged directly to home after acute stroke. In this small sample of YASS
who had limited to no deficits following stroke, levels of anxiety and depression were
low, but fatigue levels were elevated in almost half the sample. SSQOL was reduced and
all three of the psychosocial variables were significantly associated with SSQOL. Illness
perceptions as measured with the Brief IPQ indicated a moderately threatening view of
their symptoms, and as the threat increased, SSQOL decreased. Open-ended responses
suggested that participants may not understand potential symptoms post-stroke.

CHAPTER V
DISCUSSION AND CONCLUSION
Chapter V presents a discussion of the findings from this cross-sectional,
exploratory study examining the common symptoms, perception of illness, and the
presence of and relationships among psychosocial variables (anxiety, depression, and
fatigue), and their relationship to stroke specific quality of life in YASS. A discussion of
the findings in relation to prior literature and the Common Sense Model are included
along with a description of the study limitations, strengths of the study, implications for
nursing practice, and recommendations for future research.
Demographic Characteristics of Young Adult Stroke Survivors
Nearly 25% of the growing population having new onset of strokes are under age
65, with 34% of hospitalized stroke patients in 2009 under age 65 (Stroke Facts, 2019).
With the widening availability of technology and skilled providers, more young adults
experiencing large vessel stroke are receiving treatment, and rapidly recovering from
severe neurological symptoms. Many of these YASS are discharged directly from the
hospital to home because they have few to no apparent neurological deficits. However,
findings from this study suggests that these YASS do not escape post-stroke symptoms,
in spite of their rapid functional recovery.
The sample in this study was smaller than the originally projected 30 participants,
as it was an unexpected finding that 38 of the potential 80 YASS fell into categories
within the exclusion criteria, with the majority having a significant co-morbidity (e.g.
58

59
congestive heart failure, depression) or previous stroke. This level of pathology was
unexpected in a young and functionally independent population, and reduced the pool of
eligible candidates for recruitment. The 14 participants in this study were in a normal
state of health prior to experiencing their stroke, with 79% reporting working full time
prior to their stroke and no documented chronic health conditions. In terms of function
and independence prior to hospitalization for stroke, all study participants had no
neurological deficits with a premorbid mRS score of zero. Eligibility for thrombectomy
requires a large vessel occlusion (LVO) with an ischemic penumbra at risk for further
infarction. Of these YASS, 86% presented to the acute hospital with moderate to severe
stroke symptoms (NIHSS ≥5), with a mean NIHSS score of 11.
Of the nine participants who were working prior to their stroke and responded to
the work question, 100% were back to work, 78% full-time. As compared to other studies
reporting on return to work in YASS, this indicates a higher percentage and may be
attributed to the thrombectomy and subsequent reduction in functional disability.
Anderson et al. (2012) studied return to work in 83 YASS ages <60 with first ever stroke,
who were employed full or part time at baseline. The percentage who had returned to
work at least part-time (10 hours minimum) or full-time was 53% at year one and 58% at
year two. Hommel et al. (2009) assessed social dysfunction in 84 first-ever mild to
moderate stroke survivors who were of vocational age, defined as 18-64 years old. They
were assessed at three and nine months post stroke (median 7 months) and had no
apparent severe neurological deficits, with an NIHSS <4 and mRS score ≤2. Of this
sample, 59% had returned to work. Yet, for those who do return to work, more
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information is needed on their work experience and whether post-stroke symptoms
impede work ability.
Race/ethnicity and years of education among the participants in the study
represented a broad range, with three racial/ethnic groups represented and education
distributed from less than high school education to PhD degree. Stroke related to LVO
impacts individuals of different race/ethnicities, education level and gender and therefore
the study of the phenomenon of YASS being discharged home cannot be limited to a
specific group. However, as men were under represented in this study, they may be less
responsive to research participation or follow up. Data for non-participants showed that
African American men were most likely not to participate, which is of concern as young
African American males are at highest risk for stroke than other racial/ethnic groups
(Benjamin et al., 2018).
Challenges in Recruiting Young Stroke Survivors from a Public Hospital
The most challenging barrier to recruitment was the inability to contact and/or
lack of response from potential participants. It is unclear whether the efforts to contact
participants reached them and they chose to not to respond or if they did not receive the
invitations to participate. In spite of multiple attempts (2-3) and methods (telephone,
United States Postal Service, email) to contact eligible patients, most non-participants
could not be contacted or did not respond to attempts made to contact them. Some of this
was attributed to incorrect mailing addresses and telephone numbers as well as absence
of email addresses in the medical record. Challenges to capturing accurate information
may be attributed to the emergent arrival and immediate treatment of patients being
transferred from other hospitals without family present, inability to verbally communicate
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upon arrival, and inconsistency among registration processes dependent on location of
entry to the hospital. Additionally, as the time of contact was between 1 – 18 months
post-stroke, these YASS may have been too remote from the event to want to participate,
or have moved or experienced other health events or life challenges preventing
participation. For example, one male YASS returned the paper survey by mail nine
months after recruitment efforts, indicating he would have sent it sooner, but he was in
jail. His responses were recorded 24 months post-stroke therefore could not be included
in the study. There is the possibility that the remainder of those unable to be contacted
were simply not responding to the requests because of lack of interest, not wanting to
share their experiences and/or participate in research. The hospital where participants
were recruited, treats a highly vulnerable population, and the challenges faced by this
population may result from this.
There were three non-participants that originally expressed interest in
participating but when provided with the questionnaires by mail or email, never
completed the questionnaires. One potential participant in particular, followed up after
receiving the study information stating “Yes ma’am I don’t qualify” and “I’ve never had
a stroke”. This may represent a fundamental lack of understanding of the stroke diagnosis
as the medical record indicated that the individual had a stroke with treatment for large
vessel occlusion. For the two others, they may not have thought the information was
relevant to them; again, potentially indicating a lack of understanding of stroke, in this
case recovery. Additionally, the questionnaires may have contained information that they
were uncomfortable sharing due to the sensitive nature of this study and personal
information regarding wellness, even though it was anonymous. Based on the
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demographic characteristics of the sample of interest and challenges identified with
recruitment for this study, strategies are needed to reach and engage all YASS for stroke
recovery education and follow up.
Levels of Anxiety, Depression, and Fatigue in Young Adult Stroke Survivors
The hypothesis that levels of anxiety, depression and fatigue will be elevated in
this population of YASS as evidenced by definitive cases identified with questionnaire
cutoff scores, was partially supported by the data. Levels of anxiety and depression were
not high; there was only one definitive case of anxiety and depression (in the same
participant), one borderline case of anxiety, and three borderline cases of depression. The
participant with depression and anxiety was mailed information about following up with
a healthcare provider. The hypothesis was specific to results on the HADS and this
population had results below the level of clinical significance. It is possible those free of
depression and anxiety may have had more motivation and a higher comfort level leading
them to complete the questionnaires. Potentially, the non-participants had higher levels of
anxiety and depression and chose not to participate.
In general, depressive symptoms are common post stroke; one-third of stroke
survivors develop post-stroke depression (Hackett & Pickles, 2014). Broomfield et al.
(2014) examined community dwelling survivors of stroke and transient ischemic attack
(n = 4,079), and using the same HADS criteria, determined that 24% had probable or
possible depression, which is similar to the 29% having borderline cases of depression in
this study. The same group had 29% with probable or possible cases of anxiety, which is
double as compared to participants in this study. De Bruijn et al. (2015) found that 31.9%
of YASS >1-year post stroke reported anxiety on the HADS. However, Hommel et al.
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(2009) found low anxiety levels in 18-64 years of age stroke survivors who were 3-9
months post-stroke. With the findings from this dissertation, (i.e. one participant having a
definitive case of depression and three borderline, and one definitive anxiety case with
one borderline), it may be important to screen and follow up for depressive symptoms
and anxiety in this YASS population. Levels of fatigue were high as evidenced by almost
half the sample (42%) who completed the FSS (n =12) having severe fatigue, and 21%
falling just below the cutoff score of ≥4.
Fatigue as a Common Symptom of Young Stroke Survivors
Based on the three targeted psychosocial variables (i.e. anxiety, fatigue and
depression) assessed, fatigue was the most prominent symptom reported by the YASS.
The prevalence of fatigue is consistent with the literature which indicates up to half of all
stroke survivors experience fatigue (Hinkle et al., 2017) whereas one third of stroke
survivors experience depression (Hackett & Pickles, 2014). Naess & Nyland (2013)
evaluated post-stroke fatigue and its relationship to mortality in young adult ischemic
stroke survivors of first ever stroke, and their utilization of the FSS yielded a mean score
of 4.0 at the six-year and twelve-year follow-up after index stroke. This is identical to the
occurrence of reported fatigue in the current study and may indicate fatigue is a chronic
problem long after the acute recovery phase from stroke. Other studies of YASS with
varying levels of stroke severity and periods of time, found a percentage of participants
with clinically significant levels or excessive levels of fatigue ranging from 31.1% to
57.8% (de Bruijn et al., 2015; Egerton et al., 2015; Palmcrantz, Holmqvst, &
Sommerfeld, 2014).
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What is clear from these comparisons is the presence of severe fatigue in YASS,
and that fatigue may be problematic for this population of stroke survivors that has not
been widely studied. The fatigue is prevalent as early as one-month post-stroke and may
linger. For young adults this fatigue is particularly problematic as they are more likely to
be in school, working, raising children, and caring for aging parents. Fatigue can interfere
with the ability to engage in daily activities which could diminish overall function and
quality of life.
Description and Perception of Post-Stroke Symptoms
The Common Sense Model of Self- Regulation is supported with instruments
including the Brief IPQ, that evaluate individuals’ perceptions of symptoms and whether
they believe the symptoms are related to an illness, which in this case is stroke. Higher
scores on the Brief IPQ indicate that individuals perceive their illness, or in this case,
symptoms, as more threatening.
The responses to the Brief IPQ indicated that the level of threat across all eight
domains was greater than zero; they were experiencing some threat for every domain.
All YASS in the study reported varying symptom severity levels, but four theory domains
out of the eight demonstrated mean values near the midpoint of the scale, indicating a
moderately threatening view for these domains. These domains represented how much
the YASS perceived that their symptoms affected their lives, how much treatment may
help their symptoms, how concerned they were about their symptoms, and how much
their symptoms affected them emotionally. Essentially, the YASS in this study all
reported symptoms, and with increasing severity, a subsequent reduction in stroke
specific quality of life scores. These results are of great concern as it is evident these
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YASS are experiencing symptoms that they perceive as threatening. The results indicate
these YASS may be experiencing symptoms that moderately affect their lives, that they
feel may be only moderately treatable, that affect them emotionally and that they are
concerned about. Most of these individuals have returned to work yet they report
concerning symptoms that they may not have a strong belief can be managed.
Groeneveld et al. (2019) examined illness perceptions and their association with
physical and mental health in 184 Dutch stroke survivors (mean age 61.1; SD = 12.7) at
three and 12 months after start of rehabilitation post-acute stroke. IPQ domain scores
were higher for consequences than the YASS in this study which may be a reflection of
the greater physical disability experienced by those requiring a stay in inpatient
rehabilitation. However, at 12 months the treatment control (M = 4.5, SD 3.2), concern
(M = 5.1, SD 2.8), and emotional response (M = 4.6, SD 2.8) were similar to the YASS in
this dissertation study: (M = 4.3, SD 3.9; M = 4.3, SD 3.2; M = 4.1, SD 3.3, respectively).
Patients reported many of the same items as causes of their stroke as were reported by the
YASS in this sample, including stress, lifestyle and blood vessel malformation and
medications.
Participants had a broad range of symptoms and symptom attribution. Participants
were asked to: “think about symptoms since you had your stroke”, and an open-ended
question followed asking them to rank-order the three most important factors that they
believed caused their symptoms. Only three participants reported that their symptoms
resulted from stroke. Rather than explain what they thought caused their symptoms, many
participants listed actual symptoms as well as possibly the reasons they thought they had
a stroke. The responses, in conjunction with the answers to the open-ended item about
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sharing anything else they would like the student PI to know about their stroke, point to a
knowledge deficit regarding their symptoms and the pathology of stroke or a
misunderstanding of the symptom attribution question. Causal responses included
symptoms were from medications, “left vein having a dent”, a hemorrhage, functional
items such as overdoing it and hard work, poor self-care, and simply unknown, which
may indicate a lack of understanding of the relationship between the sequelae of stroke
and their own symptoms. Answers to the open-ended component of the Brief IPQ
indicated that the symptoms are mostly not being attributed to their strokes. This is
concerning as it may indicate a fundamental lack of understanding of their diagnosis,
recovery, treatment options and resources to optimize the transition back to the
community. Ideally, a YASS with no apparent neurological deficits who discharged
home from the hospital would be symptom free, and form an illness perception that is
grounded in factual clinical information about their disease process. This would assist the
individual in identifying and responding to any subsequent symptoms appropriately.
These stroke survivors may require ongoing educational resources and support available
for an extended recovery period, and successful transition back to the community.
Analysis of the open-ended responses, regarding anything else they would like us
to know about their stroke experience, yielded four themes; physical, religious faith,
gratitude, and education. The physical comments reflect the level of understanding of, but
also point to a presence of, ongoing physical symptoms. Religious faith and gratitude
reflect belief in a power and trust in and appreciation for caregivers. Both may be
leveraged in supporting the YASS, as those who have faith and trust may be more likely
to participate in their recommended plan of recovery (Seagraves, 2017). Lastly and of
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great importance, the theme of education. One participant succinctly stated what could be
gleaned from this study: “I don’t believe I was educated well enough on what happened
to me. Once I got back home and back to work, I realized things were not back to normal.
There is a difference in what the doctors think is important versus the patient”.
Relationships Among Anxiety, Fatigue, Depression, Illness Perception and Stroke
Specific Quality of Life
Hypothesis two predicted that higher levels of anxiety, fatigue, depression,
threatening illness perception would be associated with lower stroke specific quality of
life. This hypothesis was fully supported by the data. Despite the small sample size, there
were significant correlations found for the psychosocial variables examined. Higher
levels of anxiety, depression and fatigue were significantly associated with lower stroke
specific quality of life. Greater perceptions of the threat of post-stroke symptoms (higher
score means more threatening view) also were significantly associated with lower stroke
specific quality of life. Further analysis revealed that anxiety and depression were also
significantly correlated; the higher the anxiety, the higher the depression. However,
fatigue was not associated with depression or anxiety.
Stroke specific quality of life was less than ideal in this sample of YASS and the
psychosocial variables of interest may help to explain this finding. With a possible score
of 49-245, the overall mean for SSQOL was 185.67. The means of the twelve individual
subscales of SSQOL, which are scored on a 1 – 5 scale, ranged between 2.89 and 4.78,
with two below the midpoint of the scale. This indicates moderate agreement that they
have problems in the areas of personality and thinking, with negative personality changes
and lessened ability to remember and concentrate. Both of these may be precursors to the
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development of depressive symptoms and anxiety in YASS. The domains most closely
aligned with the variables of interest (anxiety, depression and fatigue), energy (M = 3.47)
and mood (M = 3.8), reflected that participants moderately disagreed with statements that
would indicate agreement with fatigue and depression. However, only three participants
strongly disagreed on all mood items, and only one participant strongly disagreed on all
energy items. The SSQOL scores reflect the prevalence of less than ideal scores in all
subscales for stroke specific quality of life, with domains (e.g. personality, thinking,
social roles) representing psychosocial and cognitive symptoms having lower scores than
domains (e.g. self-care, vision, upper extremity) representing physical symptoms. The
findings for levels of SSQOL in young adults, particularly post-thrombectomy, adds to
the limited literature and suggests further exploration is needed.
The findings for the relationships between psychosocial variables and quality of
life are consistent with the literature in other groups of YASS, as the levels of anxiety,
fatigue and depressive symptoms increase, the stroke specific quality of life decreases. In
a study examining quality of life after young stroke, de Bruijn et al. (2015) found that the
presence of fatigue, depression and anxiety were significantly associated with lower
quality of life scores in the psychological domain. Donnellan, Hickey, Hevey, & O’Neill
(2010), found that at one month and one-year post-stroke, anxiety and depression
symptoms were significantly associated with poorer health related quality of life in a
cohort of adult stroke survivors (n = 107). Guajardo et al. (2015) also found that
depressive symptoms and health related quality of life were correlated at three months
post-stroke in adult stroke survivors (n = 67). For fatigue, the American Heart
Association recommends including the measurement of quality of life in studies of post-
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stroke fatigue as fatigue has been found to significantly affect quality of life (Hinkle et
al., 2017). Increased perceptions of the threat of symptoms, as measured by the Brief
IPQ, was also associated with lower SSQOL. Groeneveld et al. (2018) examined the
relationship of stroke and aphasia specific quality of life with illness perception but in the
context of physical and communication components and not psychosocial symptoms.
There has been limited examination of this relationship in the literature and this should be
explored in future studies as indicated by the symptoms in these YASS. Despite being
physically intact, participants in this study identified some troubles with their quality of
life, suggesting that help is needed. With psychosocial symptoms being associated with
quality of life and these symptoms being perceived as threatening, improving the
symptoms may improve quality of life.
There was a strong, significant correlation between anxiety and depression, which
has been observed in other studies examining these concepts with the HADS instrument.
In a study by Stein et al. (2018) of 55 ischemic stroke survivors 6-12 months post-stroke
who were discharged to home or acute rehabilitation with minimal neurological deficits,
five of the seven patients with anxiety were found to also have depression, and those with
anxiety and depression were found to have a lower quality of life. Groeneveld et al.
(2019) found that anxiety at 12 months was also significantly associated with depressive
symptoms and anxiety at three months. Although related, anxiety and depression are
different disorders characterized by different symptoms and one does not suggest the
presence of the other, therefore both should be assessed.
Fatigue was not associated with anxiety or depression in the YASS. However,
some literature suggests a relationship exist between these variables. In the study by de
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Bruijn et al. (2015) described earlier, the presence of excessive fatigue correlated with the
presence of depression and anxiety disorders. This finding may not have been observed in
the YASS sample due to the small sample size, minimal neurological deficits that impact
function, and length of time of recovery from stroke. Despite this, assessing YASS for all
three symptoms during the post-stroke recovery period is warranted to determine where
to intervene. Illness threat perception was not associated with anxiety, fatigue or
depression in the YASS study. Due to limited prior research, these associations should be
explored further along with other potential symptoms YASS may experience post-stroke.
Lastly, of interest was the finding that the NIHSS on admission and follow-up
mRS were not correlated with quality of life. This finding regarding physical function
and quality of life is consistent with the results of the study by de Bruijn et al. (2015),
who also examined young stroke survivors following non-severe stroke. This may
indicate that the initial extent of neurological dysfunction as well as residual functional
disability are not associated with the presence of the psychosocial variables of interest,
and that stroke specific quality of life may be negatively impacted irrespective of
physical disability.
Strengths of the Study
With the exception of gender, the participants in the study represented a
demographically diverse sample reflective of the age, race, level of education, and
clinical presentation of the greater population of the enrollment site. Based on the data
available in the American Heart Association’s Get With the Guidelines (GWTG, 2019)
database and interviews with one of the founders and past presidents of the Society of
Vascular and Interventional Neurology, R. G. Nogueira (personal communication, May
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10, 2019) this hospital has the highest volume per site in the United States of stroke
thrombectomy procedures, with a young, economically and racially diverse emergent
patient population from urban, suburban, and rural areas.
Questionnaires selected were all reliable and valid based on published instrument
development and utilization research, concise in the clarity and small number of
questions, and widely utilized in the stroke patient population prior to the current study,
allowing for comparisons with the literature. The majority of the reliability coefficients
for this study were adequate. The open-ended questions allowed for additive content
allowing for exploration outside of the standardized questionnaires, particularly in
helping to understand potential knowledge deficits. The Brief IPQ was adapted for stroke
patient symptoms and this may contribute to the literature supporting use of the
questionnaire in this population.
The study investigated a phenomenon that is fairly novel, based on the new
treatments for stroke and lack of literature available with regard to the concerns for
psychosocial symptoms in this specific YASS patient population. This patient population
is increasing exponentially as the technology and trained providers disseminate and
expand availability and successful treatment rates. This study yielded results that will
contribute to the literature and begin to address this gap in research and clinical practice.
Limitations of the Study
Caution must be taken when interpreting the results of the study because the
sample size was small; there were fewer than the proposed target of 30 participants (n =
14), and two did not complete all questionnaires. Although statistically significant
relationships were found among the variables, the small sample size threatens the
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reliability of the results. Additionally, the participants were recruited from a single
hospital in the stroke belt of the southeastern United States. Therefore, findings from the
study may not be generalizable to all YASS with similar clinical experiences. However,
the study provides a basis for a larger study of this understudied phenomena.
The questionnaires selected for this study instructed participants to consider their
experiences over the previous week. As participants were recruited between one and
eighteen-months post-acute stroke, it is possible that they may have had different
responses at different time points during their recovery. Therefore, the psychosocial
variables of interest can only be interpreted for this study at the time of participation.
Clinically significant levels of anxiety, fatigue and depression may have occurred earlier
during the recovery period, and not captured with this study design. For those participants
who experienced stroke more recently, they may still develop symptoms later in
recovery. It is also unknown if participants were taking medications to manage symptoms
of post-stroke anxiety or depression and therefore may have had scores reflecting levels
with treatment.
Participants completed the brief IPQ and there is a possibility that they
misunderstood the open-ended question asking them to list the top three items in rank
order that they believed caused their symptoms. It is possible they misinterpreted the
questions a most listed symptoms that they were experiencing and only three attributed
symptoms to stroke.
Lastly, while similar for age and race, the gender of the group of patients that
participated in the study differed from those who were eligible but did not participate.
Men were underrepresented in the participant group as only 29% (n =4) of those
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participating were male and 64% (n = 18) of non-participants were male. This further
limits generalizability to male YASS.
Implications for Nursing Practice with the Common-Sense Model
This study adds to the body of research about the experiences of YASS, as there is
little known about the psychosocial symptoms in recipients of the relatively new and
widely available thrombectomy procedure for large vessel acute ischemic stroke. Existing
studies that evaluate the recovery of thrombectomy patients focus on functional outcomes
and include all ages of adult stroke survivors. How people recognize, interpret and
respond to their illness or symptoms is based on their existing knowledge and
experiences which have caused them to form an illness representation. This study
suggests that this population of YASS may experience symptoms following stroke and
perceive these symptoms as a threat. As healthcare professionals, nurses are on the
frontline and can use the proponents of the Common-Sense Model of Self-regulation to
guide interventions designed to educate and prepare YASS for the months or potentially
years after their stroke. Using information about the experiences of other YASS, nurses
can prepare YASS for the possible psychosocial symptoms that they may experience and
help to reduce the threatening perception of those anticipated symptoms (Howell et al.,
2013). Strategies can be developed, and resources provided for recognition and
management of post-stroke symptoms. Sources of support can be identified in order to
provide ongoing interventions for a favorable outcome including improvements in stroke
specific quality of life.
Notably, the most prominent symptom identified in the participants in this study
was fatigue. The American Heart Association published a scientific statement on post-
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stroke fatigue (Hinkle et al., 2017). In their review of the literature they found that
available materials about fatigue just include practical advice without sources or
references from evidence-based published guidelines. The authors concluded that
evidence-based education regarding fatigue is needed.
Typical follow-up for post-thrombectomy patients occurs at around 90 days postdischarge. These patients may benefit from follow-up at 2-4 weeks, which is the
timeframe when patients with smaller strokes and TIA are seen in the outpatient clinic
environment. This may allow for early screening and assessment of potential
psychosocial symptoms and social support systems.
Recommendations for Future Research
Inclusion Criteria
One notable finding with the study inclusion criteria was that during review of the
medical records of potential participants, initial screening criteria were met for age,
treatment and discharge directly to home, but upon further review, almost half (38 out of
80) were excluded, with 74% of those excluded having major medical comorbidities.
Broadening inclusion criteria to include this chronically ill population may yield
important information for management of their illness perception prior to discharge
home, although delineating the cause of some symptoms between stroke and other
comorbidities may be difficult. While the aged 18-55year old population was the target of
this study, there are significant numbers of older stroke survivors who are discharging
home post-thrombectomy who were working and raising children prior to their acute
stroke. Expanding inclusion criteria to include those older than 55 but younger than
retirement age may yield important information for developing age-specific interventions.
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Expansion of Variables and Questionnaires
Research in other neurological populations such as mild traumatic brain injury
(TBI) indicate that survivors of mild TBI may experience similar symptoms. There are
instruments designed to capture the presence of psychosocial symptoms in mild TBI
patients that may apply to the YASS population of interest and this research.
Additionally, this study did not include cognitive assessment of the YASS but based on
some of the open-ended comments as well as literature addressing this population, there
may be cognitive changes that can impact their recovery.
The volume, size or location of the infarct on initial and subsequent imaging (CT
or MRI) was not collected. This information is readily available in the electronic medical
record. The size or location of initial and residual infarcts may yield helpful information
about the presence and severity of psychosocial variables and symptoms present in
YASS.
Evaluation of the home environment including, levels of family and/or social
support, may provide an important role in identifying keys to successful transition of
YASS back to the community. Examining the post-discharge experiences of these YASS
may provide more information on how to appropriately screen for discharge readiness
and ongoing symptom detection and management.
Prospective Enrollment and Multiple Time Points
In order to capture baseline levels of the psychosocial variables of interest (i.e.
anxiety, fatigue, depression etc.) prior to stroke, as well as capture study participants
responses at subsequent time points, enrollment prior to hospital discharge would be
optimal. The majority of recruitment challenges in this study were related to inability to
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contact patients post-discharge, therefore obtaining participant consent and contact
information in-hospital may increase participation. Administration of questionnaires at
set time points during YASS recovery, three months, six months, one year, 18 months
and two years would yield more data and also allow comparison with other studies of
YASS that used similar lengths of follow-up. This may benefit clinicians who would be
able to target interventions to YASS at critical time points in their recovery.
Additional Clinical Sites
In order to enroll more participants as well as those from a broad range of
treatment sites, expanding enrollment to hospitals of varying size and geographical
location would allow for a larger, more economically and culturally diverse study sample.
Experiences may differ depending on support systems, provider perspective, and cultural
background. Results from a more diverse and robust patient population would allow for
generalizability of the findings.
Summary
The results of this study contribute new knowledge to the body of literature
surrounding the experiences of YASS and the presence of psychosocial symptoms postacute thrombectomy for large vessel ischemic stroke. Despite superior functional
outcomes post-thrombectomy, and the ability to discharge directly home from the acute
setting, this group of YASS experienced psychosocial symptoms similar to other stroke
patient populations, particularly post-stroke fatigue. These psychosocial symptoms were
perceived as threatening to their lives in regards to treatment, concerns and emotions. The
symptoms along with the threat may contribute to lower stroke specific quality of life.
Additional findings suggested a lack of understanding of post-stroke symptoms among
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this cohort of YASS. These YASS may be well enough to return home, but not yet well
enough to return to normal life. These individuals may need a longer recovery period and
offered support during the transition; for example, healthcare providers may have an
opportunity to prescribe later return to work. To improve stroke recovery and quality of
life for this population of YASS, tailored education and assessment of psychosocial
symptoms is needed.
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Appendix A
Demographic Data Collection Tool

Demographic Variables
Age/ Sex/ Race
Pre-morbid mRS/ Discharge mRS
Arrival NIHSS/ Discharge NIHSS
Clot location/vessel
Alteplase administered
TICI Score
Date of stroke
Years of education
Working or FT student
Contact Information
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Appendix E
Brief Illness Perception Questionnaire
For the following questions, please choose the number that best corresponds to your views.
When answering, please think about symptoms since you had your stroke.
How much do your symptoms affect your life?
No affect at all
0

1

Severely affects my life
2

3

4

5

6

7

8

9

10

How long do you think your symptoms will continue?
A very short time
0

1

2

Forever
3

4

5

6

7

8

9

10

How much control do you feel you have over your symptoms?
Absolutely no control
0

1

2

Extreme amount of control
3

4

5

6

7

8

9

10

How much do you think your treatment can help your symptoms?
Not at all
0

1

Extremely helpful
2

3

4

5

6

7

8

9

10
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How much do you experience symptoms from your stroke?
No symptoms at all
0

1

2

Many severe symptoms
3

4

5

6

7

8

9

10

How concerned are you about your symptoms?
Not at all concerned
0

1

2

Extremely concerned
3

4

5

6

7

8

9

10

How well do you feel you understand your symptoms?
Don't understand at all
0

1

2

Understand very clearly
3

4

5

6

7

8

9

10

How much do your symptoms affect you emotionally (do they make you angry, scared,
upset or depressed)?
Not at all affected emotionally
0

1

2

3

Extremely affected emotionally
4

5

6

7

8

9

10

Please list in rank-order the three most important factors that you believed caused your
symptoms. The most important factors for me:
________________________________________________________________
________________________________________________________________
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APPENDIX F

Georgia State University
Informed Consent
Title: Presence of psychosocial symptoms in young adult stroke survivors post-acute
thrombectomy for ischemic stroke
Principal Investigator: Dr. Dawn Aycock
Student Principal Investigator: Karen B. Seagraves
Purpose
The purpose of the study is to investigate how you are feeling and what symptoms you
may be experiencing after having a stroke. You are invited to participate because you
were ages 18-55 at the time of your stroke, had a procedure to treat your stroke, and
recovered well enough to discharge directly home from the hospital. A total of 40
participants will be recruited for this study. If a follow up call is needed it will take 5
minutes of your time.

Procedures
If you decide to take part, you will complete a series of 4 short questionnaires. The
questionnaires are available through an email link or can be completed on paper and
mailed back to the researcher. Participation will require 30 minutes of your time.
Additionally, basic demographic information about you, as well as the size and location
of the stroke, severity of your stroke symptoms at the time of your stroke and when you
discharged from the hospital, will be obtained from your medical record.
You may receive a follow up call after you submit your questionnaires if the researcher
has a question about missing or hard to read answers, or to let you know if you have high
scores on any of the questionnaires so you can share your symptoms with your primary
care or neurology provider.
Future Research
Researchers will remove any information that may identify and may use your data for
future research. If we do this, we will not ask for any additional consent from you.
Risks
In this study, you will not have any more risks than you would in a normal day of life.
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Benefits
This study is not designed to benefit you personally. This study will potentially assist in
understanding psychosocial symptoms in this population and influence how patients are
educated counseled and monitored for potential symptoms going forward.
Compensation
You will receive a $20 gift card for participating in this study.
Voluntary Participation and Withdrawal
You do not have to be in this study. If you decide to be in the study and change your
mind, you have the right to drop out at any time. You may skip questions or stop
participating at any time. You may refuse to take part in the study or stop at any time,
this will not cause you to lose any benefits to which you are otherwise entitled.
Confidentiality
We will keep your records private to the extent allowed by law. The following people
and entities will have access to the information you provide:
 Dr. Dawn Aycock and Karen B. Seagraves
 GSU Institutional Review Board
 Office for Human Research Protection (OHRP)
We will use a study participant number rather than your name on study records. The
information you provide will be stored on an encrypted flash drive in a locked file cabinet
in a locked, private office. The code sheet that connect you to your study participant
number will also be kept separately from the questionnaires that you complete, and the
information from your medical record. All the study materials will be destroyed after the
information is reported. Your name and other facts that might point to you will not appear
when we present this study or publish its results. The findings will be summarized and
reported in group form. You will not be identified personally. We will keep your personal
information private. Your privacy will be kept to the extent allowed by law. Data sent
over the Internet may not be secure but we are suing a secure application and not
collecting IP addresses.
The health information you give us will be used in this research study. We will remove
all information that can identify you. We will share it with other people for this research
study. If you decide you want to be in this study it means that you agree to let us use and
share your personal health information for the reasons we have listed in this consent
form.
While we are doing this research, the research team may use only the personal health
information that you have given us: your name, address, birthdate, etc.. The people and
places that will be able to look at your personal health information are: Dr. Dawn Aycock
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and Karen B. Seagraves. They will look at it so they can work on this research study. We
may also share your health information with the Georgia State University Institutional
Review Board (IRB). Your personal health information may be shared by the people or
places we have listed, but it will be shared in a way that does not fall under the protection
of federal regulations that apply to the privacy of health information. This research may
be shown to other researchers. This research may be published, but we will take steps to
make sure that you cannot be identified.
If you acknowledge this consent form by completing and returning the questionnaires you
are letting us use your personal health information until the end of the study. You have
the right to say that you do not want us to use your personal health information after we
have collected it. If you decide you don’t want us to use your information anymore you
must write a letter asking us not to use your information. You will need to send the letter
to the investigator who received your completed questionnaires. This will be the only
person who will be able to know which information is yours.

Contact Information
Contact Dr. Dawn Aycock at 404-413-1178 daycock@gsu.edu or Karen B. Seagraves at
770-597-6110 kseagraves1@student.gsu.edu
 If you have questions about the study or your part in it
 If you have questions, concerns, or complaints about this study
Contact the GSU Office of Human Research Protections at 404-413-3500 or irb@gsu.edu
 if you have questions about your rights as a research participant
 if you have questions, concerns, or complaints about the research.
Consent
You can print a copy of this consent form to keep or keep this paper copy of this form if
you are completing the questionnaires on paper and mailing them.
If you are willing to volunteer for this research, please click continue to proceed to the
questionnaires, or please complete and return the paper questionnaires in the addressed,
stamped envelope provided to you.

